Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1050.Time spend outdoors in summer,48256,-0.00268036957596996,0.0302564000952201,-0.0619829137626014,0.0566221746106615,0.929409680584272
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1060.Time spent outdoors in winter,44660,0.0106110479814554,0.0348853940968334,-0.0577643244483382,0.0789864204112489,0.761002435873824
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1070.Time spent watching television (TV),49775,0.0341790926260013,0.0320710591398311,-0.0286801832880677,0.0970383685400703,0.286555834407145
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1080.Time spent using computer,44628,-0.0217383866119268,0.0328809253842844,-0.0861850003651242,0.0427082271412706,0.50853999946143
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X1090.Time spent driving,42074,0.0176174552272084,0.0366125336757316,-0.0541431107772256,0.0893780212316424,0.630389962783898
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1160.Sleep duration,51284,0.0519004183222126,0.0286294918639882,-0.00421338573120434,0.108014222375629,0.0698691263486596
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,33857,-0.00998441898042436,0.0132060224145468,-0.035868222912936,0.0158993849520873,0.449637893783771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,33857,-0.0212955676110427,0.0118942753613175,-0.0446083473192249,0.00201721209713955,0.0734210135114938
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,33857,0.0117878308827821,0.0142548201808982,-0.0161516166717784,0.0397272784373427,0.408294042182215
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,33857,0.0133023170188357,0.0145347795180903,-0.0151858508366214,0.0417904848742927,0.360106973771896
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,33857,0.00201601387200855,0.014716173627967,-0.0268276864388069,0.030859714182824,0.891039201487031
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,33857,-0.00706002006584662,0.0281375330224123,-0.0622095847897748,0.0480895446580816,0.801888304236959
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,33857,-0.00416586100637165,0.0281954325744545,-0.0594289088523025,0.0510971868395592,0.882543633829849
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,33857,0.00651628298106791,0.0215503789752337,-0.0357224598103902,0.048755025772526,0.762373351889588
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,33857,0.000323410460493106,0.0154246155114786,-0.0299088359420049,0.0305556568629911,0.983272293130891
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,33857,-0.000657451561602279,0.0106822164165125,-0.0215945957379668,0.0202796926147623,0.950925400385104
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#18.Location of pain during the past week_Upper back,33857,-0.0326858426302471,0.0148911747793805,-0.061872545197833,-0.00349914006266126,0.0281893293411855
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#19.Location of pain during the past week_Lower back,33857,-0.0052207257942731,0.00910291569385318,-0.0230624405542253,0.0126209889656791,0.566304769468749
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,33857,-0.0189625761041886,0.0113737721231914,-0.0412551694656437,0.00333001725726647,0.0955040360842176
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,33857,0.00300312131632868,0.0162924534724371,-0.0289300874896481,0.0349363301223054,0.853761762792107
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,33857,0.0111852331568265,0.0155411356940642,-0.0192753928035393,0.0416458591171923,0.471716602233404
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,33857,0.00592064493722207,0.0217087710761373,-0.0366285463720071,0.0484698362464513,0.785066341660698
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,33857,-0.0138283399366479,0.0200389980707946,-0.0531047761554054,0.0254480962821096,0.490166299763977
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#7.Location of pain during the past week_Left hip,33857,-0.00426513773417073,0.0121250405249071,-0.0280302171629886,0.0194999416946472,0.725024068750664
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#8.Location of pain during the past week_Right hip,33857,0.0103764635632727,0.0113792112225436,-0.0119267904329128,0.0326797175594582,0.361855798145745
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,33857,0.019556276519776,0.0150708432183322,-0.00998257618815503,0.0490951292277071,0.194448655025904
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120040.Fatigue severity over the past week,33863,-0.0686930128420713,0.0530601647962977,-0.172690935842815,0.0353049101586723,0.195481413103785
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120041.Waking unrefreshed severity over the past week,33860,-0.0605943134435152,0.0514555962796312,-0.161447282151592,0.0402586552645618,0.238984329053007
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120042.Cognitive symptoms severity over the past week,33860,-0.105133684012215,0.0567585314586723,-0.216380405671213,0.00611303764678246,0.0640144278905604
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120098.Mobility problems today,33867,0.00745666199691095,0.0610175887461495,-0.112137811945542,0.127051135939364,0.902739177549665
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120099.Self-care problems today,33867,-0.0303071751010352,0.0950476898436077,-0.216600647194506,0.155986296992436,0.749837609372957
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120100.Problems doing usual activities,33867,0.0091225864537639,0.0577189635835308,-0.104006582169957,0.122251755077484,0.874419366805185
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120101.Pain or discomfort today,33867,-0.103066707215156,0.053049094057939,-0.207042931568717,0.000909517138404009,0.052063439343096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120102.Anxiety or depression today,33867,-0.0673075615937772,0.0618764373672817,-0.188585378833649,0.0539702556460949,0.276722874062632
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120103.Scale to indicate how health is today,33829,-0.00149219300852494,0.00393289782020544,-0.0092006727361276,0.00621628671907772,0.704389705378631
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,33843,-0.11129175372283,0.0653005006708495,-0.239280735037695,0.016697227592035,0.0883578257775238
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",33823,-0.0946466133224641,0.0652401833838156,-0.222517372754743,0.0332241461098145,0.146885453202001
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",33849,-0.0787450862175332,0.0509633534527796,-0.178633258984981,0.0211430865499148,0.122348123856611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,33845,-0.0873584906661351,0.0528416506814377,-0.190928126001753,0.0162111446694829,0.0983209977733296
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,33852,-0.100539850002801,0.0662348758294174,-0.230360206628459,0.0292805066228575,0.129065892288188
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120109.Feeling bad about self over the last two weeks,33825,-0.00513151707864884,0.0648044250553947,-0.132148190187222,0.121885156029925,0.936887427820466
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120110.Trouble concentrating over the last two weeks,33849,-0.0233904190385749,0.0675182675856516,-0.155726223506452,0.108945385429302,0.729026610633201
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,33839,-0.0833527440412898,0.104554012150158,-0.2882786078556,0.121573119773021,0.425342360876599
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,33802,-0.226490932718855,0.156676131619481,-0.533576150693039,0.0805942852553283,0.148323098239698
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31536,0.0599442078280071,0.0677454130342493,-0.0728368017191216,0.192725217375136,0.376270133342023
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48987,-0.0544987219383932,0.0744725365794416,-0.200464893634099,0.0914674497573122,0.464299936789131
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47169,-0.0572701352896806,0.0479089277350138,-0.151171633650308,0.0366313630709465,0.231944869874406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1289.Cooked vegetable intake,50762,-0.0141984480447597,0.0295380883903766,-0.0720931012898979,0.0436962052003785,0.630746026362009
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50264,0.0196049785745719,0.0325104220485149,-0.0441154486405174,0.0833254057896611,0.546489554027811
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1309.Fresh fruit intake,50795,-0.0231946068321078,0.0312066690300618,-0.084359678131029,0.0379704644668133,0.457332114790674
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1319.Dried fruit intake,49088,-0.0504019988394307,0.0312670729773697,-0.111685461875075,0.0108814641962139,0.106978388332032
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X134.Number of self-reported cancers,51568,-0.0847801074537684,0.0551694739064916,-0.192912276310492,0.023352061402955,0.124373233848074
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X135.Number of self-reported non-cancer illnesses,51568,-0.00450196297581295,0.0297152668296313,-0.0627438859618904,0.0537399600102645,0.879579782119068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X136.Number of operations, self-reported",51568,-0.0392690749697364,0.0298674483443964,-0.0978092737247533,0.0192711237852805,0.188595519575296
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X137.Number of treatments or medications taken,51568,-0.0251913225372962,0.0290647463319243,-0.0821582253478679,0.0317755802732755,0.386096974449101
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1438.Bread intake,50633,0.000511088979850436,0.00268034569391455,-0.00474238858022209,0.00576456653992296,0.848777593554118
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1458.Cereal intake,50209,-0.0195345071265731,0.0296948800788108,-0.0777364720810423,0.038667457827896,0.510646238637322
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1488.Tea intake,50668,-0.00865695322451954,0.00248763855854844,-0.0135327247992745,-0.0037811816497646,0.000502250284612567
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1498.Coffee intake,49405,0.0506237605044678,0.0297525637047977,-0.00769126435693575,0.108938785365871,0.0888630254120384
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X1528.Water intake,49869,0.0120387118725389,0.031402069257144,-0.0495093438714633,0.0735867676165411,0.701446275741298
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1568.Average weekly red wine intake,41033,0.020014289769106,0.0370894922835343,-0.0526811151066211,0.0927096946448332,0.589465290083842
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41035,0.0261485460197383,0.0362471842654334,-0.0448959351405112,0.0971930271799877,0.470676548396902
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1588.Average weekly beer plus cider intake,41055,0.0424569803494701,0.0455965454818388,-0.0469122487949341,0.131826209493874,0.351792273458219
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1598.Average weekly spirits intake,40984,-0.00694703776426871,0.0413893412362955,-0.0880701465874078,0.0741760710588704,0.866706440746114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1608.Average weekly fortified wine intake,41062,0.180752438248599,0.0547318633221663,0.0734779861371536,0.288026890360045,0.000960265725762872
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X1737.Childhood sunburn occasions,45122,-0.0736124296861588,0.0364054070741628,-0.144967027551518,-0.00225783182079969,0.0431872319647836
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1807.Father's age at death,44214,0.00184173315549228,0.00290284033250824,-0.00384783389622386,0.00753130020720843,0.525788664481187
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1845.Mother's age,35032,-0.00654787864015431,0.00673805951037163,-0.0197544752804827,0.00665871800017408,0.331184647962834
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1873.Number of full brothers,51056,-0.0500120416500071,0.0283903624347317,-0.105657152022081,0.00563306872206713,0.0781508949908304
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X1883.Number of full sisters,51061,-0.0145019792555101,0.0286121041977581,-0.0705817034831159,0.0415777449720958,0.612265883332784
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20015.Sitting height,51379,0.00730892584444648,0.00327991612751106,0.000880290234524809,0.0137375614543682,0.0258628742931485
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20016.Fluid intelligence score,33156,0.0753335916485606,0.0462964577343686,-0.0154074655108018,0.166074648807923,0.103730894346728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20018.Prospective memory result,33490,0.0321042514635697,0.0579145328801971,-0.0814082329816166,0.145616735908756,0.57936096896606
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33028,0.00496140172222443,0.00494016854445532,-0.00472132862490799,0.0146441320693569,0.315263299911563
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33008,0.000508678994499327,0.00492689880609901,-0.00914804266545473,0.0101654006544534,0.917770731788895
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20023.Mean time to correctly identify matches,51266,0.0012150802622177,0.00268403837521285,-0.00404563495319947,0.00647579547763488,0.650764125060513
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#1.Illnesses of father_Heart disease,48393,-0.012979187673472,0.00549939928182091,-0.023758010265841,-0.00220036508110307,0.0182774881346287
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47964,-0.00182303323605542,0.0119331863636532,-0.0252120785088156,0.0215660120367048,0.878580943962753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47934,-0.0157639580090029,0.0162151616990284,-0.0475456749390985,0.0160177589210927,0.330974025187936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#12.Illnesses of father_Severe depression,47949,0.0102150549297631,0.0131160079649599,-0.0154923206815582,0.0359224305410845,0.436091549133862
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47953,0.0128641838411338,0.00983531495796456,-0.00641303347647673,0.0321414011587444,0.19090017765503
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#2.Illnesses of father_Stroke,48117,-0.00939683374686402,0.00713412147115799,-0.0233797118303337,0.00458604433660564,0.187795200680144
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48048,0.0158183632612224,0.00909529831958601,-0.00200842144516617,0.033645147967611,0.0820161021800134
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47959,-0.00469365437961368,0.0114990038049245,-0.0272317018372658,0.0178443930780384,0.683145822187755
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48109,-0.00508679971990631,0.0080779609005825,-0.020919603085048,0.0107460036452354,0.528888236029014
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48163,-0.0133433717898766,0.00611207083210051,-0.0253230306207936,-0.00136371295895959,0.0290368939117772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20107#9.Illnesses of father_Diabetes,48036,-0.00499100360369637,0.00854264015848111,-0.0217345783143193,0.0117525711069266,0.559060384759709
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49760,-0.00173757300022144,0.00606999423056693,-0.0136347616921326,0.0101596156916897,0.77468430627192
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49631,-0.00917914787519943,0.00882948229693714,-0.0264849331771962,0.00812663742679737,0.298534807784724
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49566,0.013493095529746,0.0187982288202498,-0.0233514329579436,0.0503376240174355,0.472896249611687
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49602,-0.000434989480888468,0.00949376134414252,-0.0190427617154078,0.0181727827536309,0.963455312739146
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#2.Illnesses of mother_Stroke,49696,-0.00413294679459815,0.00698320380879353,-0.0178200262598335,0.00955413267063718,0.553962320394783
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49588,0.0151977971374454,0.0129889271357562,-0.0102605000486367,0.0406560943235275,0.241988752574981
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49583,0.000222477973620979,0.0114157561847703,-0.0221524041485289,0.0225973600957709,0.984451425284233
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49613,-0.000844251393199498,0.00907551231721475,-0.0186322555349404,0.0169437527485414,0.925884278050162
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49628,0.0192965427990288,0.0101474503949654,-0.000592459975103356,0.039185545573161,0.0572329236475159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49781,-0.00244413944807841,0.00525878492554959,-0.0127513579021556,0.00786307900599879,0.642098265035419
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49641,-0.0027797281030778,0.00828232738017213,-0.0190130897682152,0.0134536335620596,0.737159016271477
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46203,-0.00184181518415629,0.00868729723699768,-0.0188689177686718,0.0151852874003592,0.832099306765084
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46063,-0.0090297102776959,0.0342255694128733,-0.0761118263269275,0.0580524057715357,0.791913920831195
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46059,-0.036801554840867,0.0355193811567775,-0.106419541908151,0.0328164322264168,0.300168085213086
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46123,-0.00605482633999665,0.00960087021536067,-0.0248725319621036,0.0127628792821103,0.52827349173912
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46075,-0.0135120064218703,0.0203270422587317,-0.0533530092489843,0.0263289964052438,0.506229925236483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46089,-0.0177201767597022,0.014820963028345,-0.0467692642952584,0.011328910775854,0.231859647222673
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46069,-0.00785914711115171,0.0180235780219426,-0.0431853600341593,0.0274670658118559,0.662806179424092
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46068,-0.032662214343703,0.0175987592191657,-0.0671557824132677,0.00183135372586177,0.0634759278536195
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46086,-0.00868207596965096,0.0127820149932838,-0.0337348253564873,0.0163706734171854,0.496992076682972
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46088,-0.00431200094988737,0.015395338675855,-0.0344868647545632,0.0258628628547884,0.779415093990451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46276,-0.00336775084770604,0.00640686067964278,-0.0159251977798059,0.00918969608439382,0.599138428269049
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46160,-0.0112098224863719,0.00923908184858763,-0.0293184229096036,0.00689877793685989,0.225026504604924
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20127.Neuroticism score,45740,0.0330306869711151,0.0299304074196743,-0.0256329115714464,0.0916942855136766,0.269786576559079
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33156,0.0160345697646448,0.0433666593945092,-0.0689640826485932,0.101033222177883,0.71158211941626
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20161.Pack years of smoking,31660,0.00953659367281352,0.00536020177950824,-0.000969401815022636,0.0200425891606497,0.0752575816585492
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31660,0.00933766330269515,0.0052878499069896,-0.00102652251500446,0.0197018491203948,0.0774597350037741
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20191.Fluid intelligence score,31336,-0.0213620790230527,0.0520426176412711,-0.123365609599944,0.0806414515538387,0.681471948907607
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31336,0.0180460726646095,0.0512827314913591,-0.0824680810584544,0.118560226387673,0.724928736760512
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X20240.Maximum digits remembered correctly,30599,-0.0131301007284902,0.053934850495121,-0.118842407698927,0.092582206241947,0.807669811448484
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X20255.Spirometry QC measure,45317,0.0175005979893111,0.0399902713405259,-0.0608803338381196,0.0958815298167418,0.661665294648236
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20261.avMSE,30352,0.00882481069530171,0.0056506493160035,-0.00225046196406515,0.0199000833546686,0.11840431795543
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X20262.Myopia diagnosis,30352,-0.0698504612919724,0.0686423658801999,-0.204389498417164,0.0646885758332193,0.308909890770228
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20280.Glucose-lactate,39935,0.00367126408826935,0.00340318585876978,-0.00299898019491941,0.0103415083714581,0.280705861213399
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X20281.Spectrometer-corrected alanine,39974,0.0005022002450904,0.00325226229750665,-0.00587223385802264,0.00687663434820344,0.877284010587421
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32990,0.00980647292788439,0.0155577641866712,-0.0206867448779912,0.04029969073376,0.52849777867912
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32987,0.0146866266003004,0.0289638512372629,-0.0420825218247349,0.0714557750253357,0.612120583099942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32985,0.0638486634592416,0.0360741463302339,-0.00685666334801684,0.1345539902665,0.076774739248006
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32985,-0.00246375621256994,0.014603025710874,-0.031085686605883,0.0261581741807431,0.866024455970816
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32985,0.0594915593801708,0.0289342008704989,0.00278052567399304,0.116202593086349,0.0398033977711037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32992,-0.0302639008397649,0.0352160420395929,-0.0992873432373669,0.0387595415578372,0.390155983036438
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32992,0.00132846256017531,0.0235267506295449,-0.0447839686737326,0.0474408937940833,0.954971865471777
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32992,-0.0111475052927474,0.0261019246966731,-0.0623072776982267,0.0400122671127318,0.669334747885487
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32992,-0.0385692688623904,0.042510147684189,-0.121889158323401,0.0447506205986201,0.364276113724312
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32992,-0.0679528753551354,0.0509877500415145,-0.167888865436504,0.031983114726233,0.182656165216225
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32992,-0.0316878761060644,0.026849384449578,-0.0843126696272373,0.0209369174151084,0.237950106759827
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32992,-0.0342784748548169,0.0514274902764997,-0.135076355796756,0.0665194060871225,0.505084067367091
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32992,-0.0256504847203253,0.0353303893919368,-0.0948980479285214,0.0435970784878708,0.467847873708169
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32991,0.0325526019575612,0.0422674889032576,-0.0502916762928237,0.115396880207946,0.441228080261049
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32991,0.00105408121306499,0.0197607874462264,-0.0376770621815387,0.0397852246076686,0.957460612501652
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32991,0.0029339410919236,0.0319251437978289,-0.059639340751821,0.0655072229356682,0.926779140118867
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32993,-0.0306475800701078,0.0476953814474886,-0.124130527707186,0.0628353675669699,0.520520962768318
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20600.Liking for adding salt to foods,34781,0.0495438009377298,0.0468464364370805,-0.0422752144789481,0.141362816354408,0.290272237962967
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20601.Liking for aniseed,34781,-0.0732604136487969,0.0453620729969001,-0.162170076722721,0.0156492494251273,0.106338086360556
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20602.Liking for apple juice,34781,-0.0179893811473914,0.044949488963651,-0.106090379516147,0.0701116172213646,0.689007738650006
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20603.Liking for apples,34781,-0.0613529052984489,0.0473717467322391,-0.154201528893638,0.0314957182967398,0.195301920547083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20604.Liking for asparagus,34781,0.0179845143109347,0.0454633177087168,-0.0711235883981503,0.10709261702002,0.692420878292111
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20605.Liking for aubergine,34781,0.00123795858253359,0.0441496496369905,-0.0852953547059677,0.0877712718710349,0.977630746995382
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20606.Liking for avocados,34781,0.0416761552265905,0.0460849291135694,-0.0486503058360055,0.132002616289186,0.365839583270684
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20607.Liking for bacon,34781,0.025098344077202,0.0462341446950638,-0.0655205795251231,0.115717267679527,0.587242742813862
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20608.Liking for baked or steamed fish,34781,-0.0913109199427512,0.0458408053736225,-0.181158898475051,-0.00146294141045115,0.046406854190096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20609.Liking for bananas,34781,-0.0739019221586831,0.0455509753983894,-0.163181833939526,0.0153779896221601,0.104748182457467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20610.Liking for barbequed or grilled meat,34781,0.0462993726287131,0.0457849348892316,-0.0434390997541809,0.136037845011607,0.311927216184972
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20611.Liking for beef steak,34781,0.0618001791245491,0.0460229645858207,-0.0284048314636595,0.152005189712758,0.179362459751615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20612.Liking for beetroot,34781,-0.0272474665444806,0.0447080988531343,-0.114875340296624,0.0603804072076627,0.54223790686246
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20613.Liking for bell pepper,34781,0.0177273930466319,0.0453746399927947,-0.0712069013392456,0.106661687432509,0.696034864004397
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20614.Liking for bicycling,34781,-0.125228600488237,0.0452007327022265,-0.213822036584601,-0.0366351643918735,0.00560705260251036
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20615.Liking for biscuits,34781,0.00386701451884033,0.045780615615262,-0.0858629920870732,0.0935970211247538,0.932685679073138
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20616.Liking for bitter foods,34781,0.0145413691952261,0.0454020088699201,-0.0744465681898172,0.103529306580269,0.748762336924469
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20617.Liking for bitter or ale,34781,0.00110854174393707,0.0466941598573964,-0.0904120115765599,0.092629095064434,0.981060076133365
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20618.Liking for black olives,34781,-0.0468328755543105,0.0451260364750708,-0.135279907045449,0.0416141559368282,0.299376400448176
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20619.Liking for black pepper,34781,0.0609358348699902,0.0456171295201794,-0.0284737389895614,0.150345408729542,0.181640718180037
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20620.Liking for blue cheese,34781,-0.000860601965962311,0.0454469066958563,-0.0899365390898406,0.088215335157916,0.984892187419081
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20621.Liking for bolognese sauce,34781,-0.0258339447935139,0.0455740060626791,-0.115158996676365,0.0634911070893371,0.570823662387285
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20622.Liking for broad beans,34781,0.00747830656596386,0.0447649206264712,-0.0802609378619196,0.0952175509938474,0.867328240187714
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20623.Liking for broccoli,34781,-0.0422668456633544,0.0461718257707762,-0.132763624174076,0.0482299328473669,0.359989924529752
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20624.Liking for brown rice,34781,-0.0333635771388805,0.0453380545933112,-0.12222616414177,0.0554990098640094,0.461817641845129
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20625.Liking for brussel sprouts,34781,-0.0398212687223732,0.0442923866137768,-0.126634346485376,0.0469918090406294,0.368644617542191
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20626.Liking for burgers (meat),34781,0.00980299696419882,0.0454082674018851,-0.0791972071434959,0.0988032010718936,0.829081087095963
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20627.Liking for burn of spicy foods,34781,-0.0333091253884402,0.0466117593797507,-0.124668173772752,0.0580499229958712,0.474867606307446
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20628.Liking for butter on bread,34781,0.0718419107668009,0.0463276222157224,-0.018960228776015,0.162644050309617,0.120995631612776
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20629.Liking for butternut squash,34781,-0.00114084494792044,0.0440563159721747,-0.0874912242533829,0.085209534357542,0.979341468492346
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20630.Liking for cabbage,34781,-0.0152138878540898,0.0451509565097708,-0.10370976261324,0.073281986905061,0.736156885369603
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20631.Liking for cake,34781,0.004523633945703,0.0449836940670072,-0.0836444064256311,0.0926916743170371,0.91990040439506
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20632.Liking for cake icing,34781,-0.0126004367628953,0.0448392840193469,-0.100485433440815,0.0752845599150246,0.778705805127731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20633.Liking for capers,34781,0.0429022369903909,0.0446321318531256,-0.0445767414417352,0.130381215422517,0.336453504714514
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20634.Liking for cauliflower,34781,-0.0865478745139656,0.0449313836911582,-0.174613386548636,0.00151763752070454,0.0541039414352775
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20635.Liking for cereal or granola bar,34781,0.00486355149357871,0.0435163260976414,-0.0804284476577984,0.0901555506449558,0.911012836812607
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20636.Liking for cheesecake,34781,0.0261677925760953,0.0449298561165385,-0.0618947254123203,0.114230310564511,0.560300347303192
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20637.Liking for cherries,34781,0.098678364611101,0.0509477352654812,-0.0011791965092421,0.198535925731444,0.0527903573734734
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20638.Liking for chicken,34781,-0.0785951820366895,0.0477451882736423,-0.172175751053028,0.0149853869796493,0.0997657433288341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20639.Liking for chilli pepper,34781,-0.0689595218071264,0.0461275243966979,-0.159369469624654,0.0214504260104014,0.134951395544283
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20640.Liking for chips or french fries,34781,-0.00787886360457424,0.0448613293725497,-0.0958070691747717,0.0800493419656232,0.860590383869252
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20641.Liking for cigarette smoking,34781,0.138748201783908,0.0767850193995777,-0.0117504362392641,0.289246839807081,0.0707961191588239
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20642.Liking for cod,34781,-0.126635248792399,0.0455580123348339,-0.215928952968673,-0.0373415446161245,0.0054516309934441
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20643.Liking for coffee with sugar,34781,-0.0229506435948921,0.0516061172108216,-0.124098633328102,0.0781973461383183,0.656526242513317
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20644.Liking for coffee without sugar,34781,-0.00400550802049844,0.045348198821203,-0.0928879777100563,0.0848769616690594,0.929617833682736
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20645.Liking for coriander,34781,-0.0789029997377244,0.044316388253149,-0.165763120713897,0.0079571212384477,0.0750321760054651
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20646.Liking for corn flakes,34781,-0.00284685483182521,0.043918766979402,-0.0889276381114531,0.0832339284478027,0.948317841121509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20647.Liking for cream,34781,0.0349182558787323,0.0443737249419345,-0.0520542450074594,0.121890756764924,0.43135093485302
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20648.Liking for croissant,34781,0.0260196651463241,0.0460653937613796,-0.06426850662598,0.116307836918628,0.572193573014395
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20649.Liking for cucumber,34781,-0.0850582421773748,0.0459870431089485,-0.175192846670914,0.00507636231616433,0.0643978902180152
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20650.Liking for curry,34781,-0.0456740523215469,0.0459725128729051,-0.135780177552441,0.0444320729093471,0.320485821438134
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20651.Liking for dairy products,34781,0.0653565591237126,0.0455522127339053,-0.0239257778347418,0.154638896082167,0.151385387036758
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20652.Liking for dark chocolate,34781,0.0840398470611833,0.0468231553007326,-0.00773353732825256,0.175813231450619,0.0727092140671012
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20653.Liking for diet fizzy drinks,34781,-0.00671726950621994,0.0471459004067297,-0.0991232343034102,0.0856886952909703,0.886704970434215
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20654.Liking for dried fruit,34781,0.00433372053453119,0.0453624128105821,-0.0845766085742097,0.0932440496432721,0.923891353648777
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20655.Liking for eggs,34781,0.0321847292317301,0.0458791623339509,-0.0577384289428136,0.122107887406274,0.483000097157204
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20656.Liking for exercising alone,34781,-0.058081697598805,0.0450533571274437,-0.146386277568595,0.0302228823709847,0.197365871405559
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20657.Liking for exercising with others,34781,-0.00298110579966881,0.045190318528189,-0.0915541301149193,0.0855919185155816,0.947404740957676
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20658.Liking for extra virgin olive oil,34781,-0.0263746911586297,0.0459224321350247,-0.116382658143278,0.0636332758260187,0.565756135408122
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20659.Liking for fatty foods,34781,0.0755191078914126,0.0440114009058254,-0.0107432378840051,0.16178145366683,0.0862105884678108
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20660.Liking for fresh tomatoes,34781,-0.00317334381220498,0.0495069944974104,-0.100207053027129,0.0938603654027193,0.948892720428395
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20661.Liking for fried chicken,34781,-0.011820179803537,0.0452726106231082,-0.100554496624829,0.0769141370177551,0.794029098248386
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20662.Liking for fried or battered fish,34781,-0.0305180948317723,0.0459331386484849,-0.120547046582803,0.0595108569192581,0.506447540256985
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20663.Liking for fruit,34781,-0.0508559223351458,0.051264181306699,-0.151333717696276,0.0496218730259841,0.321203137881942
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20664.Liking for garlic,34781,-0.0434039374339435,0.0448456680747842,-0.131301446860521,0.0444935719926337,0.33314132791875
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20665.Liking for gherkins,34781,0.0588135338834935,0.0449045675806163,-0.0291994185745145,0.146826486341501,0.190311262224986
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20666.Liking for globe artichoke,34781,0.0371646471755819,0.0452241810485421,-0.0514747476795605,0.125804042030724,0.411217079476081
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20667.Liking for goat's cheese,34781,-0.0303635049500113,0.0444378553376878,-0.117461701411879,0.0567346915118568,0.494445167041965
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20668.Liking for going to a cafe,34781,-0.0140854563706223,0.0458816909363513,-0.104013570605871,0.0758426578646263,0.758853261561681
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20669.Liking for going to the gym,34781,0.00926335262590271,0.044589669862573,-0.0781324003047405,0.0966591055565459,0.835430923566917
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20670.Liking for going to the pub,34781,0.0297876408819309,0.0454840422901643,-0.0593610820067911,0.118936363770653,0.512544732026239
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20671.Liking for grapefruit,34781,-0.0266903198698278,0.0456456978224451,-0.11615588760182,0.0627752478621647,0.558743373041064
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20672.Liking for green olives,34781,-0.0926608655118619,0.0447593121199794,-0.180389117267022,-0.00493261375670224,0.0384581463466915
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20673.Liking for haddock,34781,-0.0537305498296931,0.0461826524422199,-0.144248548616444,0.036787448957058,0.244679642422619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20674.Liking for ham,34781,-0.00743665353451115,0.0461564821641626,-0.0979033585762699,0.0830300515072476,0.872003387944803
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20675.Liking for hard cheese,34781,0.000899867249663402,0.0471793050301808,-0.091571570609491,0.0933713051088178,0.984782962406471
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20676.Liking for herring,34781,0.0819745444885613,0.0454208850978326,-0.00705039030319067,0.170999479280313,0.0711388063849887
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20677.Liking for honey,34781,-0.0469622461778319,0.044296382896835,-0.133783156655628,0.0398586642999647,0.289086431183552
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20678.Liking for horseradish or wasabi,34781,0.0140627308346229,0.0459797720034735,-0.0760576222921851,0.104183083961431,0.759728047092456
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20679.Liking for ice cream,34781,-0.00150506893243161,0.0465616520552761,-0.0927659069607727,0.0897557690959095,0.974214122234132
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20680.Liking for jam,34781,0.00242296507257809,0.0448982887348377,-0.0855776808477037,0.0904236109928599,0.95696358092057
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20681.Liking for kiwi fruit,34781,0.0511219733721762,0.0448895880187679,-0.0368616191446089,0.139105565888961,0.254797119775697
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20682.Liking for lager,34781,0.039037203123066,0.0455052219404106,-0.0501530318801388,0.128227438126271,0.390988562134861
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20683.Liking for lamb,34781,0.0485643090140032,0.0459743537052065,-0.0415454242482015,0.138674042276208,0.290840016403134
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20684.Liking for lemons,34781,-0.0190382399491402,0.0449294214542869,-0.107099905999543,0.0690234261012622,0.671766756512649
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20685.Liking for lentils or beans,34781,-0.0444048672303809,0.0456175199474567,-0.133815206327396,0.0450054718666342,0.330368931940927
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20686.Liking for liver,34781,0.0640050011861952,0.0450102910875209,-0.0242151693453458,0.152225171717736,0.155054103155436
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20687.Liking for mackerel,34781,0.0238940899483411,0.0447078376393908,-0.0637332718248649,0.111521451721547,0.593041961611996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20688.Liking for marzipan,34781,0.0263359090952245,0.0453108072640224,-0.0624732731422595,0.115145091332708,0.561099504141772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20689.Liking for mayonnaise,34781,-0.00778770068636936,0.0448986827107472,-0.0957891187994339,0.0802137174266951,0.862300705028526
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20690.Liking for melon,34781,0.00190731155777018,0.0473250354921663,-0.0908497580068757,0.0946643811224161,0.967852836071233
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20691.Liking for milk chocolate,34781,-0.0534794386120251,0.0447816054564116,-0.141251385306592,0.0342925080825417,0.232416315252445
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20692.Liking for mushrooms,34781,0.00811701912064073,0.0467368837092048,-0.0834872729494008,0.0997213111906822,0.862124446356351
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20694.Liking for orange juice,34781,0.0200166758298875,0.0446354715623738,-0.0674688484323651,0.10750220009214,0.653839517578865
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20695.Liking for oranges,34781,-0.0883980143669051,0.046227621455556,-0.179004152419795,0.00220812368598466,0.0558738853686941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20696.Liking for pasta,34781,-0.0370410745044913,0.0445487355959052,-0.124356596272465,0.0502744472634828,0.40572566582761
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20697.Liking for pears,34781,-0.0635384255950993,0.0463002333412216,-0.154286882943894,0.0272100317536949,0.169995755004571
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20698.Liking for pizza,34781,0.0644798694492202,0.0461013100313507,-0.0258786982122271,0.154838437110668,0.161946243807073
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20699.Liking for plain yogurt,34781,-0.0181086611025604,0.0449903185350826,-0.106289685431322,0.0700723632262016,0.687323478195718
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20700.Liking for plums,34781,0.0492648707514608,0.0471280807690076,-0.0431061675557942,0.141635909058716,0.295890312953243
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20701.Liking for pollock,34781,-0.0831151983994292,0.0460275672852395,-0.173329230278499,0.0070988334796402,0.0709834055773642
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20702.Liking for pork chop,34781,0.0827056565364734,0.0463069959716984,-0.00805605556805544,0.173467368641002,0.0741238475571458
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20703.Liking for porridge,34781,-0.108948519034883,0.0455042034261582,-0.198136757750153,-0.0197602803196127,0.0166720481798837
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20704.Liking for potato crisps,34781,-0.0115441947976009,0.0462131320271282,-0.102121933570772,0.0790335439755703,0.802744407586128
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20705.Liking for potatoes,34781,-0.0527804303744281,0.0456563698191841,-0.142266915220029,0.0367060544711727,0.247692982938873
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20706.Liking for prawns,34781,0.046369758694633,0.046585618326595,-0.0449380532254931,0.137677570614759,0.319581436764669
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20707.Liking for raw carrots,34781,-0.000829663866988881,0.045779314254781,-0.0905571198063597,0.0888977920723819,0.985540986652389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20708.Liking for red meat,34781,0.0730560093502897,0.0464623327433823,-0.0180101628267395,0.164122181527319,0.115895267315882
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20709.Liking for red wine,34781,0.0267670508121516,0.0450152853395909,-0.0614629084534465,0.11499701007775,0.552109625390351
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,34781,0.0223262313606076,0.0470650860449572,-0.0699213372875084,0.114573800008724,0.635246626552119
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20711.Liking for roast chicken,34781,-0.0533833725822619,0.0479426792882416,-0.147351023987216,0.0405842788226917,0.265526851752083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20712.Liking for salad dressing,34781,-0.0118190331575812,0.045940590004457,-0.101862589566317,0.0782245232511545,0.79697719992936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20713.Liking for salad leaves,34781,0.0104828376779777,0.0478671717373489,-0.0833368189272261,0.104302494283182,0.826655565435025
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20714.Liking for salami,34781,0.0233850614719958,0.045613396167558,-0.0660171950164179,0.112787317960409,0.608186376831404
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20715.Liking for salmon,34781,-0.0220745298678699,0.0479917799990741,-0.116138418666055,0.0719893589303153,0.645551170941776
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20716.Liking for salty foods,34781,-0.00106718214078068,0.0452496790885806,-0.0897565531543986,0.0876221888728373,0.981184649060271
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20717.Liking for salty pretzels,34781,0.0511877391249757,0.0442438001158259,-0.035530109102043,0.137905587351994,0.247320725759257
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20718.Liking for sardines,34781,0.0489558623095046,0.045021662236199,-0.0392865956734454,0.137198320292455,0.276892268160646
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20719.Liking for sausages (meat),34781,0.0260909220782117,0.0453676376560044,-0.0628296477275569,0.11501149188398,0.565236299909475
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20720.Liking for savoury biscuits,34781,0.0239533363696366,0.0443398913554613,-0.0629528506870676,0.110859523426341,0.589056352783482
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20721.Liking for shellfish (other than prawns),34781,0.0939269738845703,0.0459434910963122,0.00387773133579838,0.183976216433342,0.0409391532022493
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20722.Liking for skimmed milk,34781,-0.0698099994929349,0.0456903756165576,-0.159363135701388,0.0197431367155181,0.126569783933873
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20723.Liking for smoked fish,34781,0.0376896475667292,0.045832447391935,-0.0521419493214635,0.127521244454922,0.410904988826601
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20724.Liking for soft cheese,34781,0.0150729327833048,0.0460472288851936,-0.0751796358316747,0.105325501398284,0.743420125851556
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20725.Liking for soy sauce,34781,0.0182263710281137,0.0453549057476829,-0.0706692442373449,0.107121986293572,0.687794595260253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20726.Liking for soya milk,34781,-0.0347243163498383,0.0457794950331096,-0.124452126614733,0.0550034939150566,0.448161592231231
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20727.Liking for spicy foods,34781,-0.0380466029811996,0.0457065056192381,-0.127631353994906,0.051538148032507,0.405196196219446
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20728.Liking for spinach,34781,-0.0346027311271668,0.0443503823936654,-0.121529480618751,0.0523240183644175,0.435283588239692
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20729.Liking for spirits,34781,0.0433566652297299,0.0455303673363015,-0.0458828547494211,0.132596185208881,0.340988357651099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20730.Liking for strawberries,34781,-0.0208950603537936,0.05192342509557,-0.122664973541111,0.0808748528335236,0.687382783350526
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20731.Liking for sweet coffee house drinks,34781,-0.0451133321899602,0.0474246741970479,-0.138065693616174,0.0478390292362538,0.341493222536729
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20732.Liking for sweet foods,34781,-0.0145590283855702,0.0444279283420628,-0.101637767936013,0.0725197111648729,0.743145214310255
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20733.Liking for taking the stairs,34781,-0.069501743542139,0.046302271132556,-0.160254194961949,0.0212507078776706,0.133374789973638
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20734.Liking for tea with sugar,34781,-0.0333375664950156,0.0601226094195537,-0.151177880957341,0.0845027479673096,0.579253505920322
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20735.Liking for tea without sugar,34781,-0.0337309650112152,0.0471319285126453,-0.126109544896,0.0586476148735696,0.47421057431756
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20736.Liking for tomato ketchup,34781,-0.0443248095214898,0.0465371300869171,-0.135537584491847,0.0468879654488678,0.340885454838567
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20737.Liking for tinned tuna,34781,-0.0539889435024988,0.0454127119527077,-0.142997858929806,0.0350199719248083,0.234525698712513
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20738.Liking for turnip (white),34781,-0.0286204844541741,0.0445873636321249,-0.116011717173139,0.0587707482647908,0.520954472239394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20739.Liking for vegetables,34781,-0.0107577431115406,0.0519937614069209,-0.112665515469105,0.0911500292460243,0.836088525513932
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20740.Liking for vinegar,34781,-0.019797796660545,0.0454186278415467,-0.108818307229976,0.0692227139088865,0.662921329351476
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20741.Liking for watching television,34781,0.0260540401523691,0.0464125783122376,-0.0649146133396166,0.117022693644355,0.574566168508261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20742.Liking for whisky,34781,0.0979708607795965,0.0479895470401138,0.00391134858097349,0.19203037297822,0.0412261173225976
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20743.Liking for white bread,34781,-0.0120083332403659,0.0449687944042516,-0.100147170272699,0.0761305037919673,0.789445986948136
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20744.Liking for white rice,34781,-0.000568991027629071,0.0447818131757094,-0.0883413448520195,0.0872033627967613,0.989862716346265
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20745.Liking for white wine,34781,0.0150853957436971,0.045063697014906,-0.0732394504055187,0.103410241892913,0.737815073831273
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,34781,-0.00618862062329483,0.0476338995854649,-0.099551063810806,0.0871738225642164,0.89663184767065
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20747.Liking for whole milk,34781,0.0209933512786386,0.044638170706016,-0.0664974633051528,0.10848416586243,0.638150322391933
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20748.Liking for wholemeal bread,34781,-0.00295228863242708,0.0471196254687179,-0.0953067545511142,0.08940217728626,0.950042301509013
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X20749.Liking for working up a sweat,34781,-0.0911366278277436,0.0449174449586787,-0.179174819946754,-0.00309843570873342,0.0424858770574347
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21001.Body mass index (BMI),51471,-0.0238178706007535,0.00954571546213537,-0.0425274729065388,-0.00510826829496817,0.0125967605810263
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21002.Weight,51479,0.00364127063792685,0.00588846054571169,-0.00790011203166806,0.0151826533075218,0.536334073043415
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X21021.Pulse wave Arterial Stiffness index,33377,0.00692256215785899,0.0045672291184865,-0.00202920691437456,0.0158743312300925,0.129629922789905
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34221,0.0907418644399982,0.0464116354119414,-0.000224940967406967,0.181708669847403,0.0505934608146811
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34236,-0.0201016998903798,0.0501187060203324,-0.118334363690231,0.0781309639094718,0.688368675156303
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34237,-0.02742167504476,0.0497691024333781,-0.124969115814181,0.0701257657246611,0.581661414621558
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21040.Satisfaction with bowel habits,34190,-0.00962791918923542,0.0454758332580558,-0.0987605523750248,0.079504713996554,0.832333765730719
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34170,-0.0148142153615111,0.0489245213197379,-0.110706277148197,0.0810778464251752,0.762050790698602
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21042.Greatest number of times bowels opened per day,34183,0.0615819355410333,0.0494983804337777,-0.0354348901091711,0.158598761191238,0.213485292946007
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21043.Least number of times bowels opened per week,34096,0.0202517192485532,0.0500037484272393,-0.0777556276688358,0.118259066165942,0.685483538161324
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21044.Average number of times bowels opened per day,34144,0.0269738707641365,0.0556506212197617,-0.0821013468265964,0.136049088354869,0.627899942387758
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34240,-0.0463462369158652,0.0510200808399213,-0.146345595362111,0.0536531215303805,0.363693480512314
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34234,-0.0615685960008034,0.0514981414837826,-0.162504953309017,0.0393677613074105,0.231901251081533
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34237,0.142853340721283,0.0630403035310638,0.0192943458003975,0.266412335642168,0.023469237848099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34237,0.0587968112931972,0.0538296992116701,-0.0467093991616762,0.164303021748071,0.274739331128467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34234,0.0645821524590727,0.0829900713151667,-0.098078387318654,0.227242692236799,0.436475061753199
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34235,0.0179852856823339,0.0585260242499267,-0.0967257218475223,0.13269629321219,0.758618476904213
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34235,-0.0756396465876566,0.134002253539892,-0.338284063525846,0.187004770350532,0.572450327956914
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34239,0.0354473518239178,0.0555359375732952,-0.0734030858197409,0.144297789467576,0.52330784594232
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34238,-0.0629929361289456,0.0576066024609497,-0.175901876952407,0.0499160046945158,0.274200361626083
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,33981,-0.0757293748655354,0.0520646728756765,-0.177776133701861,0.0263173839707906,0.145833716654466
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34235,-0.0576980821937179,0.051604375223034,-0.158842657630865,0.0434464932434288,0.263558113923358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34237,-0.10833142425118,0.0642872089448113,-0.23433435378301,0.0176715052806498,0.0919980243699243
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34239,0.00688245409995432,0.0510603120625469,-0.0931957575426376,0.106960665742546,0.892780148236058
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34237,0.0711103517042737,0.0513622107674228,-0.0295595813998749,0.171780284808422,0.166240729293573
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X21100.Water hardness (USGS classification),51332,-0.00118231977784434,0.0288244963656299,-0.0576783326544789,0.0553136930987902,0.967281945100342
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2139.Age first had sexual intercourse,47732,0.0102012837723086,0.00305465061472234,0.00421416856745279,0.0161883989771644,0.000840335731445138
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2149.Lifetime number of sexual partners,46229,-0.0348479906411416,0.0325963927428018,-0.098736920417033,0.0290409391347499,0.285047697329928
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22032.IPAQ activity group,45369,-0.00203130224306362,0.0329100435409833,-0.0665349875833909,0.0624723830972636,0.950784119141531
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22033.Summed days activity,46034,-0.00149843815777935,0.0028075594931927,-0.00700125476443705,0.00400437844887835,0.593543845951153
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22034.Summed minutes activity,45369,2.14316167999029e-05,0.00284202193792186,-0.00554893138152695,0.00559179461512675,0.993983301297197
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22037.MET minutes per week for walking,44354,0.000326663860037168,0.00287276770124486,-0.00530396083440276,0.00595728855447709,0.909468433386996
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22038.MET minutes per week for moderate activity,45369,8.20165962279659e-05,0.00280811076696553,-0.00542188050702447,0.0055859136994804,0.976699747230907
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22039.MET minutes per week for vigorous activity,45369,-0.0205461458607596,0.0331300398845403,-0.0854810240344585,0.0443887323129393,0.535154831785632
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X22040.Summed MET minutes per week for all activity,44354,-0.000920956823456823,0.00292607072632873,-0.00665605544706112,0.00481414180014748,0.752960989089282
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X2217.Age started wearing glasses or contact lenses,47768,-0.000353504929393147,0.00273975107505707,-0.005723417036505,0.00501640717771871,0.897336511497876
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X22501.Year ended full time education,31197,-0.00519140937731122,0.0123521859780683,-0.029401693894325,0.0190188751397026,0.674292375655932
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X22506.Tobacco smoking,31154,0.0667833800794617,0.13307812504,-0.194049744998938,0.327616505157861,0.615799450816273
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49727,-0.0379585319102125,0.0720734001952808,-0.179222396292963,0.103305332472538,0.598430918955374
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23098.Weight,51062,0.00397597504570905,0.00593413959936363,-0.00765493856904366,0.0156068886604618,0.502852699188525
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23099.Body fat percentage,51063,0.000231302196061537,0.0060987407832519,-0.0117222297391122,0.0121848341312353,0.969746790548937
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23100.Whole body fat mass,51055,-0.000673400677330535,0.00584130900745698,-0.0121223663319462,0.0107755649772851,0.908222082774244
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23101.Whole body fat-free mass,51062,0.0039152950612776,0.00488423438786468,-0.00565780433893718,0.0134883944614924,0.422780544441896
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23102.Whole body water mass,51062,0.00443309300444878,0.00490085574584473,-0.00517258425740689,0.0140387702663045,0.365709434525728
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23104.Body mass index (BMI),51062,-0.024588329413651,0.00966892315957326,-0.0435394188064146,-0.00563724002088738,0.0109952958275078
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23105.Basal metabolic rate,51060,0.00413522538154863,0.00532437728110659,-0.0063005540894203,0.0145710048525175,0.437366903290867
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23106.Impedance of whole body,51057,0.00373163615110232,0.00399108652994871,-0.00409089344759714,0.0115541657498018,0.349800627582015
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23107.Impedance of leg (right),51059,0.00191485359313612,0.0032688156717236,-0.00449202512344213,0.00832173230971437,0.558018722256136
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23108.Impedance of leg (left),51058,0.0016680280985033,0.00323455754786778,-0.00467170469531755,0.00800776089232416,0.606075415814753
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23109.Impedance of arm (right),51049,0.00521217405355788,0.00400379615729088,-0.00263526641473224,0.013059614521848,0.192993287083198
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23110.Impedance of arm (left),51057,0.00382647695607422,0.00401427286595025,-0.00404149786118826,0.0116944517733367,0.340488313033227
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23111.Leg fat percentage (right),51058,0.00766162739278996,0.00963988482409701,-0.0112325468624402,0.0265558016480201,0.426746178399309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23112.Leg fat mass (right),51057,0.00189381353106456,0.0110678305210866,-0.0197991342902651,0.0235867613523942,0.864138783768939
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23113.Leg fat-free mass (right),51057,0.00353861719676232,0.00496058283970667,-0.00618412516906275,0.0132613595625874,0.475637279043464
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23114.Leg predicted mass (right),51056,0.00356955987734115,0.00497914992782459,-0.00618957398119506,0.0133286937358773,0.473441191595892
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23115.Leg fat percentage (left),51053,0.00806302983172727,0.00991797606711173,-0.0113762032598117,0.0275022629232663,0.416241792860717
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23116.Leg fat mass (left),51053,0.00025203907921453,0.0110848799779467,-0.021474325677561,0.0219784038359901,0.981860076603749
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23117.Leg fat-free mass (left),51051,0.00396281690390719,0.00509024215727514,-0.00601405772435208,0.0139396915321665,0.436273893890432
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23118.Leg predicted mass (left),51050,0.00398931294207592,0.00510962079874801,-0.00602554382347018,0.014004169707622,0.434959200235372
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23119.Arm fat percentage (right),51050,-0.00190653242850588,0.00676885761610396,-0.0151734933560697,0.0113604284990579,0.778204607938163
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23120.Arm fat mass (right),51046,-0.00556706366319344,0.00610104538853402,-0.0175251126247201,0.00639098529833325,0.361525937181251
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23121.Arm fat-free mass (right),51048,0.00228990548740409,0.00475429147169282,-0.00702850579711384,0.011608316771922,0.63005841425154
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23122.Arm predicted mass (right),51047,0.0012966006206914,0.00475285956790066,-0.00801900413239389,0.0106122053737767,0.785005756978295
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23123.Arm fat percentage (left),51044,-0.00321702041431498,0.00760255435780874,-0.0181180269556201,0.0116839861269901,0.672189290508143
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23124.Arm fat mass (left),51043,-0.00444935707832334,0.0062551627127393,-0.0167094759952924,0.00781076183864568,0.476898664089533
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23125.Arm fat-free mass (left),51043,0.00483645548972461,0.00512350293640651,-0.00520561026563215,0.0148785212450814,0.345191319023374
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23126.Arm predicted mass (left),51041,0.00400967874461734,0.00512945201220712,-0.00604404719930861,0.0140634046885433,0.434399454246851
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23127.Trunk fat percentage,51039,-0.000404569113815179,0.00385621870035436,-0.00796275776650973,0.00715361953887937,0.916445297067736
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23128.Trunk fat mass,51035,0.00145565065901336,0.00444179114000517,-0.00725025997539678,0.0101615612934235,0.743128196608372
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23129.Trunk fat-free mass,51029,0.00375869395770097,0.00456840045954586,-0.00519537094300891,0.0127127588584108,0.410652268389055
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X23130.Trunk predicted mass,51026,0.00383892898654051,0.00457540185973517,-0.00512885865854043,0.0128067166316214,0.401456396615143
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23400.Total Cholesterol,39980,0.00287825837184655,0.00337226075104854,-0.00373137270020859,0.00948788944390169,0.393389694084679
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39980,0.00331999747288842,0.00326524958502817,-0.00307989171376679,0.00971988665954363,0.309280206267125
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39980,0.00360585303433421,0.00325988909032894,-0.00278352958271051,0.00999523565137893,0.268688465213521
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23403.VLDL Cholesterol,39980,0.00276629148624654,0.00319866478835828,-0.0035030914989357,0.00903567447142877,0.387147141285641
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23404.Clinical LDL Cholesterol,39980,0.00356872596788631,0.00326724893971183,-0.00283508195394887,0.00997253388972149,0.27473031688358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23405.LDL Cholesterol,39980,0.00295970461445268,0.00326753050996636,-0.00344465518508138,0.00936406441398674,0.365059748142435
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23406.HDL Cholesterol,39980,-6.21287614422689e-05,0.0037594791723427,-0.00743070793923395,0.00730645041634942,0.986815055283467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23407.Total Triglycerides,39980,0.000650807352848954,0.00346281642111159,-0.00613631283252976,0.00743792753822767,0.850924866134081
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23408.Triglycerides in VLDL,39980,0.000570749312565233,0.00346289768578904,-0.00621653015158129,0.00735802877671175,0.86908905352979
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23409.Triglycerides in LDL,39980,0.00169508951336242,0.00345518898517959,-0.00507708089758958,0.00846725992431441,0.623721683505941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23410.Triglycerides in HDL,39980,-0.00050047551843828,0.00326737114910726,-0.00690452297068851,0.00590357193381196,0.878263241662657
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39980,0.00154618106572134,0.0034363155986143,-0.00518899750756269,0.00828135963900537,0.652750495472214
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23412.Phospholipids in VLDL,39980,0.00199993956496975,0.0032944828684034,-0.0044572468571009,0.00845712598704041,0.543821824692492
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23413.Phospholipids in LDL,39980,0.00373468802636319,0.00324333038683181,-0.00262223953182715,0.0100916155845535,0.249545201172135
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23414.Phospholipids in HDL,39980,-0.000855189517486899,0.00364809897832081,-0.00800546351499568,0.00629508448002188,0.814661565559888
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23415.Total Esterified Cholesterol,39980,0.00275445367001406,0.00338264309244501,-0.00387552679117816,0.00938443413120629,0.415491116649619
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39980,0.00322139695077558,0.00317928081037752,-0.00300999343756437,0.00945278733911552,0.310957952476861
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39980,0.00277399488054779,0.00326144924522473,-0.00361844564009267,0.00916643540118826,0.395037732664994
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39980,-9.63764871180053e-05,0.00373402958598495,-0.00741507447564852,0.0072223215014125,0.979408964518984
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23419.Total Free Cholesterol,39980,0.00314161886978989,0.00334482389977299,-0.00341423597376518,0.00969747371334496,0.347618083630488
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23420.Free Cholesterol in VLDL,39980,0.00219438426281974,0.00325575010766937,-0.00418688594821223,0.00857565447385171,0.50031964953077
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23421.Free Cholesterol in LDL,39980,0.00341179779078182,0.00329334303155571,-0.00304315455106737,0.00986675013263101,0.30023323289843
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23422.Free Cholesterol in HDL,39980,-1.82374464605779e-05,0.00377681004970943,-0.00742078514389106,0.0073843102509699,0.996147254974161
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39980,0.0018464168657067,0.00336154239759405,-0.00474220623357763,0.00843503996499103,0.582823483465468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23424.Total Lipids in VLDL,39980,0.00156918225005211,0.00336099733407433,-0.00501837252473357,0.0081567370248378,0.640592325037964
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23425.Total Lipids in LDL,39980,0.00310228061637988,0.00326124406883927,-0.0032897577585451,0.00949431899130485,0.341488833770904
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23426.Total Lipids in HDL,39980,-0.000650576001135445,0.00369215532748452,-0.0078872004430051,0.00658604844073421,0.860135239221984
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39980,0.000508271652202576,0.00345272050881772,-0.00625906054508016,0.00727560384948531,0.882968941033207
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23428.Concentration of VLDL Particles,39980,0.00250326938843588,0.00324667593107387,-0.0038602154364689,0.00886675421334067,0.440703648083865
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23429.Concentration of LDL Particles,39980,0.003479929823664,0.00323631195164064,-0.00286324160155166,0.00982310124887966,0.282267711705052
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23430.Concentration of HDL Particles,39980,-5.73049732738434e-05,0.00346011849773291,-0.00683913722883035,0.00672452728228266,0.986786600765609
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39980,-0.00124001895065768,0.00364933639605439,-0.00839271828692429,0.00591268038560892,0.734017017901907
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23432.Average Diameter for LDL Particles,39980,0.00713239574458007,0.00333969448606702,0.000586594551888706,0.0136781969372714,0.0327241070775672
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23433.Average Diameter for HDL Particles,39980,-0.000877313851299591,0.00395518951341984,-0.00862948529760249,0.0068748575950033,0.824462100400579
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23434.Phosphoglycerides,39966,0.000510544371963995,0.00345441385270887,-0.0062601067793454,0.00728119552327339,0.882506641368579
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39966,0.00012230886732389,0.00366243363458652,-0.00705606105646568,0.00730067879111346,0.973359613634337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23436.Total Cholines,39966,0.000999655746210288,0.00346166537108996,-0.00578520838112604,0.00778451987354662,0.772754476160022
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23437.Phosphatidylcholines,39966,0.00044476702107459,0.00346490829127135,-0.00634645322981726,0.00723598727196644,0.897863146497948
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23438.Sphingomyelins,39965,0.00350453536383834,0.00347915388002712,-0.00331460624101482,0.0103236769686915,0.313808597039933
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23439.Apolipoprotein B,39980,0.00374515019376989,0.00323434420282904,-0.00259416444377502,0.0100844648313148,0.246909654777796
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23440.Apolipoprotein A1,39980,-0.000815782105136947,0.0035785892353247,-0.00782981700637335,0.00619825279609946,0.819678839073166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39980,0.00381557593695505,0.00326290015858924,-0.00257970837387985,0.01021086024779,0.242267804165016
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23442.Total Fatty Acids,39966,0.000989035680144408,0.00346598506876413,-0.00580429505463329,0.0077823664149221,0.775376097144252
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23443.Degree of Unsaturation,39966,0.00310269453484303,0.00363515384773158,-0.00402220700671087,0.0102275960763969,0.393381431105145
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23444.Omega-3 Fatty Acids,39966,0.00199027244442714,0.00339909856080617,-0.00467196073475295,0.00865250562360723,0.558200260842995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23445.Omega-6 Fatty Acids,39966,0.00182711009271422,0.00334459653285612,-0.00472829911168378,0.00838251929711221,0.584876426697544
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39966,0.00207392335578844,0.00337632479645856,-0.00454367324527033,0.00869151995684722,0.539056043286692
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39966,0.000734634477975904,0.00355866325099255,-0.0062403454939695,0.00770961444992131,0.83645344090733
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23448.Saturated Fatty Acids,39966,0.000414304023272736,0.00354008710171853,-0.00652426669609557,0.00735287474264104,0.906836087286716
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23449.Linoleic Acid,39966,0.00185761396243905,0.00331192195779124,-0.00463375307483177,0.00834898099970988,0.574882674958368
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23450.Docosahexaenoic Acid,39966,0.0019438580352111,0.00357067551225275,-0.0050546659688043,0.00894238203922649,0.586177483025574
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39966,0.0019043603330704,0.003395537578597,-0.00475089332097971,0.00855961398712052,0.574913302189437
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39966,0.000890049369557376,0.00379156247165313,-0.00654141307488275,0.0083215118139975,0.814409953603114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39966,0.00159394126456778,0.00380799206662205,-0.00586972318601143,0.00905760571514699,0.675530449117043
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39966,-0.00052771422263545,0.00374587768176766,-0.00786963447890007,0.00681420603362917,0.887967631091401
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39966,-0.00238250268272303,0.00353746277752999,-0.00931592972668181,0.00455092436123575,0.500635416276002
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39966,0.00235532282485891,0.00363774314937768,-0.00477465374792133,0.00948529939763916,0.51733858232017
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39966,0.00148576861352678,0.00361553546252488,-0.00560068089302199,0.00857221812007555,0.681122111351916
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39966,0.0011248362741178,0.00378772677268971,-0.00629910820035404,0.00854878074858963,0.766494385590618
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39964,-0.0014413677844919,0.00337987091747438,-0.00806591478274169,0.00518317921375788,0.669781186263152
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23460.Alanine,39974,0.00217539239428049,0.00324057739489086,-0.00417613929970559,0.00852692408826657,0.502040841506343
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23461.Glutamine,39935,0.00477452960018522,0.00326832630918991,-0.001631389965827,0.0111804491661974,0.144077313299022
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23462.Glycine,39959,0.0010248280154662,0.00311623948073421,-0.00508300136677285,0.00713265739770526,0.742260735484298
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23463.Histidine,39960,0.00170849389141515,0.00318343300410862,-0.00453103479663774,0.00794802257946804,0.591494404411663
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39969,0.0025506818613912,0.00325234362407056,-0.0038239116417871,0.00892527536456949,0.432899744214847
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23465.Isoleucine,39976,0.00472268985675542,0.00318780400562645,-0.00152540599427243,0.0109707857077833,0.138497170955517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23466.Leucine,39977,0.00255163083993305,0.00324851552499578,-0.00381545958905868,0.00891872126892479,0.432186548600571
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23467.Valine,39969,0.00122892594991371,0.00328264106962972,-0.00520505054656055,0.00766290244638797,0.708133356358369
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23468.Phenylalanine,39977,0.000544493632039977,0.00317707988042179,-0.00568258293358672,0.00677157019766668,0.863925807205071
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23469.Tyrosine,39961,-0.00197348731630648,0.00319854966659141,-0.00824264466282565,0.00429567003021268,0.537247459508278
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23470.Glucose,39947,0.00295302112867072,0.00338493557399579,-0.00368145259636103,0.00958749485370248,0.383003181356291
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23471.Lactate,39947,0.00180628413764117,0.00317402128350522,-0.00441479757802906,0.0080273658533114,0.569307510733836
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23472.Pyruvate,39936,0.00447884140389717,0.00327933521375416,-0.00194865561506099,0.0109063384228553,0.172028729298655
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23473.Citrate,39978,-0.000402361865054146,0.00325521640785398,-0.00678258602444795,0.00597786229433966,0.901629428868512
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23474.3-Hydroxybutyrate,39786,0.000935406300761197,0.00307019323035196,-0.00508217243072864,0.00695298503225104,0.760619022984439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23475.Acetate,39967,-0.00134492633170028,0.00330001196803106,-0.00781294978904116,0.0051230971256406,0.683608265805297
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23476.Acetoacetate,39979,0.00046279575768357,0.00316535109828121,-0.0057412923949476,0.00666688391031474,0.883760059901487
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23477.Acetone,39979,0.0036336154916499,0.00318081917016134,-0.00260079008186634,0.00986802106516613,0.253325303710064
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23478.Creatinine,39506,-5.94760548183626e-07,0.0037690126153742,-0.00738785948668162,0.00738666996558525,0.99987409371512
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23479.Albumin,39979,0.00378502748923471,0.00329323242699041,-0.0026697080676665,0.0102397630461359,0.250435549876902
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23480.Glycoprotein Acetyls,39980,0.00490424567507172,0.00350389939132985,-0.00196339713193479,0.0117718884820782,0.161637028021135
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39980,-0.00180535912411944,0.00349363693507885,-0.00865288751687399,0.00504216926863511,0.605333603152788
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39980,-0.00253282518719866,0.0034927553292047,-0.00937862563243987,0.00431297525804254,0.468361516584511
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39980,-0.00127248957684715,0.00343950614903822,-0.00801392162896206,0.00546894247526776,0.711415199294561
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39980,-0.00182513316575333,0.00343681369400724,-0.00856128800600752,0.00491102167450086,0.595389054434149
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39980,-0.0011338905514417,0.00341633443344996,-0.00782990604100362,0.00556212493812022,0.739967226838353
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39980,-0.00200696871116299,0.00345331192666378,-0.008775460087424,0.00476152266509802,0.56113287209119
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39980,-0.00226180960803848,0.00351654679591283,-0.00915424132802763,0.00463062211195066,0.520109973209135
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39980,0.000210664146339745,0.0034302753454508,-0.00651267553074382,0.00693400382342331,0.951030939680022
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39980,0.000194558396038969,0.00343867477369174,-0.00654524416039685,0.00693436095247479,0.954880916914769
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39980,0.00039870461110432,0.00340805251369322,-0.0062810783157344,0.00707848753794304,0.906870293674629
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39980,0.00119597675744833,0.00331254214927219,-0.00529660585512516,0.00768855937002183,0.718070724354435
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39980,0.00185674007037884,0.00324596513786448,-0.00450535159983553,0.00821883174059321,0.567320234509478
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39980,0.000434929349455265,0.00338377934997075,-0.0061972781764874,0.00706713687539793,0.897728372504101
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39980,6.23578445155458e-05,0.00347722472528612,-0.00675300261704526,0.00687771830607635,0.985692355990647
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39980,0.000745889523111944,0.00339937002794028,-0.005916875731651,0.00740865477787489,0.826325832836468
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23496.Total Lipids in Large VLDL,39980,0.00102464787378873,0.00339258896035504,-0.00562482648850714,0.0076741222360846,0.762636781938029
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23497.Phospholipids in Large VLDL,39980,0.000773631457074463,0.00337533007131196,-0.00584201548269697,0.0073892783968459,0.818715154601761
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23498.Cholesterol in Large VLDL,39980,0.00153473233234909,0.003278910695616,-0.00489193263105826,0.00796139729575644,0.639747076423396
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39980,0.00194936917405832,0.00320072545943872,-0.00432405272644157,0.0082227910745582,0.542506972444718
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39980,0.000973537982463447,0.0033629049274085,-0.00561775567525721,0.00756483164018411,0.77220787660323
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23501.Triglycerides in Large VLDL,39980,0.000981622841652222,0.00344444151664171,-0.00576948253096553,0.00773272821426998,0.775657504821626
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39980,0.00258615713304671,0.00322548484460411,-0.00373579316237734,0.00890810742847076,0.422687495730482
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39980,0.00273681464216191,0.00326027543713632,-0.00365332521462527,0.0091269544989491,0.401233815172989
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39980,0.00298089400984899,0.0032171993271718,-0.00332481667140773,0.00928660469110571,0.354174952816174
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39980,0.00397458720743734,0.00323903671936265,-0.00237392476251345,0.0103230991773881,0.219807643649248
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39980,0.00441089175518509,0.00329282203285503,-0.00204303942921078,0.010864822939581,0.180412083330667
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39980,0.00321376734096255,0.00320809590347366,-0.00307410062984582,0.00950163531177091,0.316471337563462
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39980,0.00153587146687703,0.00338247696908214,-0.00509378339252397,0.00816552632627802,0.649786887295702
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39980,0.00228198064137768,0.00325134892435089,-0.00409066325035006,0.00865462453310542,0.48277912767829
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23510.Total Lipids in Small VLDL,39980,0.00242237501644058,0.00323348596034656,-0.00391525746583867,0.00876000749871983,0.453776470586694
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23511.Phospholipids in Small VLDL,39980,0.0032396304977609,0.00319422280181161,-0.00302104619378986,0.00950030718931167,0.310495703512725
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23512.Cholesterol in Small VLDL,39980,0.00343731650438672,0.00315746773159572,-0.00275132024954088,0.00962595325831433,0.276333640752684
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39980,0.0032405349671841,0.00313937483969296,-0.00291263971861409,0.0093937096529823,0.301983731346784
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39980,0.00363932133399909,0.00319858042280265,-0.00262989629469411,0.00990853896269229,0.255224625110242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23515.Triglycerides in Small VLDL,39980,0.000914116184041362,0.00335458687012194,-0.00566087408139764,0.00748910644948037,0.785243217178504
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39980,0.00353336041858478,0.00326919905118308,-0.00287426972173405,0.00994099055890361,0.279801501524539
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39980,0.00345712288393267,0.00326770966073694,-0.00294758805111174,0.00986183381897708,0.290087796628965
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39980,0.00343694415691931,0.00326321676393747,-0.00295896070039812,0.00983284901423674,0.292248278683986
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39980,0.0036915629682218,0.00332310829803034,-0.00282172929591767,0.0102048552323613,0.266638705855929
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39980,0.00372332527042451,0.00334633783531845,-0.00283549688679966,0.0102821474276487,0.265873116021432
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39980,0.00354108938617536,0.0032762840294357,-0.0028804273115186,0.00996260608386933,0.27979179204772
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39980,0.0016298099067053,0.0033330884636048,-0.00490304348196012,0.00816266329537071,0.624863546349451
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23523.Concentration of IDL Particles,39980,0.00494329020253085,0.0032756223033066,-0.00147692951195009,0.0113635099170118,0.131289785729554
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23524.Total Lipids in IDL,39980,0.00408345034678287,0.00336395223080973,-0.00250989602560421,0.0106767967191699,0.224810195275689
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23525.Phospholipids in IDL,39980,0.00383590151521894,0.00337601928531267,-0.00278109628399389,0.0104528993144318,0.255881927873883
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23526.Cholesterol in IDL,39980,0.0042618928078747,0.00336668691338515,-0.0023368135423602,0.0108605991581096,0.205567469484312
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39980,0.00454899481023234,0.00335825725113849,-0.00203318940199909,0.0111311790224638,0.175574278495771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23528.Free Cholesterol in IDL,39980,0.00338790239834793,0.00338686738171652,-0.00325035766981644,0.0100261624665123,0.317178226763408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23529.Triglycerides in IDL,39980,0.00209886917046574,0.00338023211393457,-0.00452638577284601,0.00872412411377749,0.534658368293085
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23530.Concentration of Large LDL Particles,39980,0.00434179353771982,0.00325170143426942,-0.00203154127344824,0.0107151283488879,0.181818216038261
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23531.Total Lipids in Large LDL,39980,0.00313929660047262,0.00328598991172905,-0.00330124362651632,0.00957983682746156,0.339411581294432
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23532.Phospholipids in Large LDL,39980,0.00345719282971996,0.00326919396882203,-0.00295042734917123,0.00986481300861115,0.290297086063367
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23533.Cholesterol in Large LDL,39980,0.00311464216058804,0.00329572906045619,-0.00334498679790609,0.00957427111908216,0.344645977200406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39980,0.00306419990088408,0.00328288781577231,-0.00337026021802965,0.0094986600197978,0.350635474914732
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39980,0.00325758729880052,0.00332776544671261,-0.00326483297675619,0.00978000757435724,0.327639044214094
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23536.Triglycerides in Large LDL,39980,0.00195029163998688,0.00342761941417549,-0.00476784241179708,0.00866842569177085,0.569369082910132
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39980,0.00181601786656302,0.00322794751174395,-0.00451075925645512,0.00814279498958115,0.573720773917741
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23538.Total Lipids in Medium LDL,39980,0.00281202021709009,0.00324240260274021,-0.00354308888428071,0.00916712931846089,0.385810581276032
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23539.Phospholipids in Medium LDL,39980,0.00360028646690485,0.0032197536919238,-0.0027104307692658,0.0099110037030755,0.263504467710156
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23540.Cholesterol in Medium LDL,39980,0.00256090436591025,0.00324176389332928,-0.00379295286501515,0.00891476159683564,0.429555884861159
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39980,0.00220354260427465,0.00325287721194096,-0.00417209673112963,0.00857918193967893,0.498153792468249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39980,0.00348005593832397,0.00324352774423169,-0.00287725844037015,0.00983737031701809,0.283322280916614
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23543.Triglycerides in Medium LDL,39980,0.00133816692241091,0.00347781912562229,-0.00547835856380877,0.00815469240863059,0.700411721458569
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23544.Concentration of Small LDL Particles,39980,0.0022100847918958,0.00321891227939604,-0.00409898327572043,0.00851915285951203,0.492349071641501
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23545.Total Lipids in Small LDL,39980,0.00364199432198176,0.00324773938866067,-0.00272357487979316,0.0100075635237567,0.262137679819384
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23546.Phospholipids in Small LDL,39980,0.0047206851994673,0.00323150938849256,-0.00161307320197811,0.0110544436009127,0.14408238989394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23547.Cholesterol in Small LDL,39980,0.00322788186389664,0.00323881766260707,-0.00312020075481323,0.0095759644826065,0.318962814356486
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39980,0.0028679293284062,0.00325932692942285,-0.00352035145326259,0.00925621011007499,0.37891919585844
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39980,0.004046157829265,0.00322292378292049,-0.00227077278525916,0.0103630884437892,0.209341300548478
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23550.Triglycerides in Small LDL,39980,0.00100533196484887,0.00350389083904849,-0.00586229407968617,0.00787295800938392,0.774178364888951
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39980,0.000636949777157347,0.00375252121826393,-0.00671799181063996,0.00799189136495466,0.865217491539467
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39980,0.000850117770479635,0.00377803898878028,-0.00655483864752971,0.00825507418848898,0.821970086857932
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39980,0.000699525790106691,0.0037818806074354,-0.00671296020046669,0.00811201178068007,0.853256778989492
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39980,0.00105634478831325,0.00375168195098578,-0.00629695183561888,0.00840964141224538,0.778280329883065
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39980,0.00103078544433318,0.00381127833871993,-0.00643932009955788,0.00850089098822425,0.78681258303491
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39980,0.00139076503154498,0.00349905759799218,-0.00546738786051968,0.00824891792360965,0.69102750440837
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39980,0.000375787136730258,0.0033908610082827,-0.00627030043950384,0.00702187471296436,0.911757730001641
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23558.Concentration of Large HDL Particles,39980,-0.000706442266612821,0.0039722272907548,-0.00849200775649223,0.00707912322326659,0.858846728214937
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23559.Total Lipids in Large HDL,39980,-0.000601036633070935,0.0039512938822144,-0.00834557264221116,0.00714349937606929,0.879101091296358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23560.Phospholipids in Large HDL,39980,-0.000704894653045483,0.00389946360693739,-0.00834784332264276,0.0069380540165518,0.856552762189599
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23561.Cholesterol in Large HDL,39980,-0.000276280604545358,0.00395028651469189,-0.00801884217334145,0.00746628096425074,0.944242806764545
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39980,-0.000281511104584623,0.00393929960912992,-0.00800253833847927,0.00743951612931003,0.943030810176481
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39980,-0.000218395565990247,0.00394526847677471,-0.00795112178046869,0.00751433064848819,0.955855301837791
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23564.Triglycerides in Large HDL,39980,-0.0007889004891362,0.00335272047067539,-0.00736023261165997,0.00578243163338757,0.813977756708634
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39980,-0.00111987624282012,0.00354826316487839,-0.00807447204598177,0.00583471956034153,0.7523008827983
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23566.Total Lipids in Medium HDL,39980,-0.000973418064252252,0.00351690969418914,-0.00786656106486296,0.00591972493635845,0.781951020260936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23567.Phospholipids in Medium HDL,39980,-0.00109040041683903,0.00349511018967041,-0.00794081638859303,0.00576001555491497,0.755060794610948
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23568.Cholesterol in Medium HDL,39980,-0.000621320510807028,0.00355915893800458,-0.007597272029296,0.00635463100768194,0.861420210743301
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39980,-0.000636734714132314,0.00354140997047285,-0.0075778982562591,0.00630442882799447,0.857314323607076
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39980,-0.000557099327758397,0.00360469573526643,-0.0076223029688806,0.00650810431336381,0.877179498424528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23571.Triglycerides in Medium HDL,39980,-0.000725831094822533,0.00323630044389122,-0.00706897996484933,0.00561731777520426,0.822543919476679
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23572.Concentration of Small HDL Particles,39980,0.000536822359879143,0.00319625241904669,-0.00572783238145237,0.00680147710121066,0.866621905676599
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23573.Total Lipids in Small HDL,39980,-5.56543564608033e-06,0.00323077713383685,-0.0063378886179663,0.00632675774667414,0.99862556242556
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23574.Phospholipids in Small HDL,39980,-0.000240556493280736,0.00326412551267437,-0.0066382424981225,0.00615712951156103,0.941252377831864
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23575.Cholesterol in Small HDL,39980,0.000654445400403972,0.0032027740379932,-0.00562299171406269,0.00693188251487064,0.83809279656269
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39980,0.000541225816737492,0.00316765724230835,-0.00566738237818687,0.00674983401166185,0.864336100384099
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39980,0.000733804597683568,0.00332027481866467,-0.00577393404689919,0.00724154324226633,0.825089742781798
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23578.Triglycerides in Small HDL,39980,-0.000490211157463491,0.00334130298260905,-0.00703916500337723,0.00605874268845025,0.883360798844338
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39123,0.000930942795927783,0.00307242461198238,-0.00509100944355769,0.00695289503541325,0.761894619369597
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39123,0.00334504353539752,0.00322266088959134,-0.00297137180820151,0.00966145887899655,0.299298497756392
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39123,0.00236771757367573,0.00314256039498319,-0.00379170080049133,0.00852713594784279,0.451200154179581
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39123,0.00283866352858255,0.00328685691805966,-0.00360357603081438,0.00928090308797948,0.387799397541329
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39123,-0.00174256850873425,0.00312105652656355,-0.00785983930079881,0.00437470228333032,0.576629985494184
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39746,-0.00106868976009168,0.0030054436960198,-0.0069593594042905,0.00482197988410713,0.722156516068495
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39746,0.00414295141099835,0.00340458499897121,-0.00253003518698522,0.0108159380089819,0.223670887104526
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39746,0.00429475518566316,0.00341254683399879,-0.00239383660897447,0.0109833469803008,0.208223314578554
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39746,0.00224144086486202,0.0032317889179567,-0.0040928654143331,0.00857574714405715,0.487968458265643
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39746,-0.00327151631282181,0.00326510881262496,-0.00967112958556674,0.00312809695992311,0.31637759754337
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39975,-0.000433261911114788,0.00318986020914692,-0.00668538792104276,0.00581886409881318,0.891961599384988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39975,0.00223675882776151,0.00314288822809327,-0.0039233020993013,0.00839681975482432,0.476668105642847
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39975,0.00336409678668676,0.00329801321980806,-0.00310000912413704,0.00982820269751055,0.30772662658012
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39975,-0.000106957925695598,0.00302716941852195,-0.00604020998599862,0.00582629413460743,0.971814940803247
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39975,-0.00141946739799143,0.00297043902804273,-0.00724152789295518,0.00440259309697231,0.63275336980926
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39980,0.00326147812841612,0.00331997934502044,-0.00324568138782395,0.00976863764465618,0.325928453048985
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39980,0.00303708494339145,0.00347442259807403,-0.00377278334883365,0.00984695323561655,0.382062873799358
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39980,0.00316152413839307,0.00350085529635286,-0.00370015224245852,0.0100232005192447,0.366501730739314
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39980,0.00263734268563266,0.00339653668730009,-0.00401986922147552,0.00929455459274084,0.437477473403271
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39980,-0.00315144083852713,0.00344850520381077,-0.00991051103799625,0.00360762936094198,0.360806146654266
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39980,0.00347277481680259,0.00338472874333733,-0.00316129352013857,0.0101068431537437,0.304901560803806
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39980,0.00368994345789656,0.00331058465973262,-0.00279880247517937,0.0101786893909725,0.265043550316427
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39980,0.00398211329062091,0.0032161935669028,-0.00232162610050858,0.0102858526817504,0.215681099438183
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39980,0.00283872704419423,0.00339753355810423,-0.00382043872969006,0.00949789281807852,0.403434565717096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39980,-0.00364790664410287,0.00333837328508799,-0.0101911182828753,0.0028953049946696,0.274533788564259
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39980,0.00163784104877142,0.00339837426591999,-0.00502297251243177,0.00829865460997461,0.629849393095474
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39980,0.00161137102556911,0.00353203738068216,-0.00531142224056793,0.00853416429170614,0.648241232771815
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39980,0.00169238005386963,0.00355400016334798,-0.00527346026629241,0.00865822037403167,0.633945579335999
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39980,0.00119689334173176,0.00344472426762134,-0.00555476622280607,0.0079485529062696,0.728252774314394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39980,-0.0021814458014582,0.00352752874222467,-0.00909540213621855,0.00473251053330215,0.536316653174111
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39980,-0.00174068664691838,0.00316960596668943,-0.00795311434162966,0.0044717410477929,0.582889296561752
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39980,0.00219869362981196,0.00335662862062515,-0.00438029846661333,0.00877768572623724,0.512457914763838
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39980,0.00367848625183604,0.00334558344714716,-0.00287885730457241,0.0102358298082445,0.271564831956851
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39980,-0.00185713169631951,0.00344253735097435,-0.00860450490422925,0.00489024151159022,0.589573117907416
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39980,-0.0017518521034538,0.00347169028139088,-0.00855636505497993,0.00505266084807234,0.613839445337192
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39980,0.00106203867448837,0.00316101083915826,-0.00513354257026183,0.00725761991923857,0.736889950511244
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39980,0.0018897712730471,0.00347888080629144,-0.00492883510728412,0.00870837765337833,0.586991351335132
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39980,0.00104761064842596,0.00320633101975609,-0.00523679815029598,0.0073320194471479,0.743875069040227
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39980,0.00161748539094994,0.00347022793442698,-0.00518416136052695,0.00841913214242683,0.641147955169087
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39980,-0.00158213729222144,0.00345981788353614,-0.00836338034395227,0.00519910575950939,0.647469601306136
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39980,0.00488713512615853,0.00312435358774978,-0.00123659790583103,0.0110108681581481,0.11778938881952
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39980,-0.00123676544424124,0.00321537685974203,-0.00753890408933563,0.00506537320085315,0.700508756044156
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39980,-0.00248071516257963,0.00325705564773289,-0.0088645442321361,0.00390311390697683,0.44628439064406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39980,0.00223388276738627,0.00353575145298653,-0.00469619008046732,0.00916395561523986,0.527527798927408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39980,-0.00183762374677282,0.00334155697174258,-0.00838707541138828,0.00471182791784264,0.582375024928756
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39980,0.00313885351720757,0.00319565747943024,-0.0031246351424757,0.00940234217689083,0.326004494437379
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39980,-0.00177331985753032,0.0032335934170978,-0.00811116295504201,0.00456452323998137,0.583421503074972
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39980,-0.00245542412698107,0.00322179323334545,-0.00877013886433815,0.003859290610376,0.445994208082082
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39980,0.00206142134620161,0.00345966690962698,-0.00471952579666727,0.00884236848907049,0.551288213035558
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39980,-0.00235026537306841,0.00342251668654922,-0.00905839807870489,0.00435786733256806,0.492277785430946
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39978,-0.00109082036037222,0.00368206466303898,-0.00830766709992863,0.00612602637918419,0.767041324364982
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39978,0.00133671054427179,0.00367636966395362,-0.0058689739970773,0.00854239508562088,0.716165225400715
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39978,8.26940175266321e-05,0.00367833454690336,-0.00712684169440395,0.00729222972945721,0.982064257917169
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39978,0.000647820685616077,0.00390350771476712,-0.00700305443532747,0.00829869580655963,0.868191689557008
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39978,0.000382938223163352,0.00366996587827457,-0.0068101948982548,0.0075760713445815,0.916897859891286
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39980,0.000379512651280621,0.00381613040017611,-0.00710010293306456,0.0078591282356258,0.920782584630655
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39980,-0.000658287396221489,0.0037969656459722,-0.008100340062327,0.00678376526988402,0.862361319668387
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39980,-0.00167923120686654,0.00383442090680215,-0.00919469618419875,0.00583623377046567,0.661438721794954
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39980,0.00312274690601777,0.00368373986784808,-0.00409738323496446,0.010342877047,0.396611989725187
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39980,0.000201589715905284,0.00368843550623544,-0.00702774387631617,0.00743092330812674,0.956414396626613
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39980,0.000157479532740418,0.00359426076185,-0.00688727156048559,0.00720223062596642,0.965053099553162
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39980,0.000375125840632605,0.00350575105241758,-0.00649614622210586,0.00724639790337107,0.914787990983293
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39980,-0.000160823563819202,0.00348509288224837,-0.006991605613026,0.00666995848538759,0.963194368796211
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39980,0.00160478757830964,0.00376865327993735,-0.00578177285036756,0.00899134800698685,0.670241116685842
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39980,-0.000568610880701685,0.00341570941605577,-0.00726340133617099,0.00612617957476762,0.867789779707023
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39980,-0.00210789793074963,0.00334148186549456,-0.00865720238711896,0.00444140652561971,0.52816274562771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39980,0.00173876402271369,0.00334620954861763,-0.00481980669257687,0.00829733473800426,0.603334483682801
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39980,0.000743563233268829,0.00335887187529805,-0.00583982564231534,0.007326952108853,0.824804996606793
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39980,0.0023546592840419,0.00341504811241025,-0.0043388350162822,0.009048153584366,0.490521995440164
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39980,-0.000989724550956038,0.00341387519889175,-0.00768091994078386,0.00570147083887178,0.771887171127796
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51175,-0.00448941360490924,0.00278024985893385,-0.00993870332841959,0.000959876118601103,0.106376249949759
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51175,-0.00590585453192266,0.00272358781648248,-0.0112440866522283,-0.000567622411616997,0.0301363134951574
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49344,-0.00391111471686081,0.00262167814592928,-0.0090496038828822,0.00122737444916058,0.135754728646704
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49344,-0.00488067375224691,0.00285354533233383,-0.0104736226036212,0.000712275099127401,0.0872063467366748
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49344,-0.00408037775745305,0.0028051919042053,-0.00957855388969545,0.00141779837478934,0.145798010671175
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49344,-0.00296335842038497,0.00256738231883745,-0.00799542776530636,0.00206871092453643,0.248415574404799
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24009.Traffic intensity on the nearest road,51175,-0.114574536587477,0.0718493265934819,-0.255399216710702,0.0262501435357474,0.110802326469373
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24010.Inverse distance to the nearest road,51175,0.00139561010131623,0.0024252973467745,-0.00335797269836179,0.00614919290099425,0.564999440885686
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24011.Traffic intensity on the nearest major road,51175,-0.0025500296652126,0.00243686180027363,-0.00732627879374891,0.00222621946332371,0.295367397313997
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24012.Inverse distance to the nearest major road,51175,-0.00201451132541489,0.00247797805816359,-0.00687134831941552,0.00284232566858575,0.416244929885354
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24013.Total traffic load on major roads,51175,-0.0379544394022859,0.0461848553704094,-0.128476755928288,0.0525678771237166,0.411201452007713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24015.Sum of road length of major roads within 100m,51175,-0.0466549717219944,0.0450770734894661,-0.135006035761348,0.0416960923173591,0.300676198494579
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51175,-0.00253270361170745,0.0027650550590334,-0.00795221152741291,0.002886804303998,0.359691629673229
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51175,-0.00310974301942033,0.00275872820812373,-0.00851685030734284,0.00229736426850219,0.25965202746382
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51175,-0.00277479224517096,0.00273164581415831,-0.00812881804092124,0.00257923355057932,0.309736199187051
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51113,-0.00175407667395803,0.00268416601638683,-0.00701504206607622,0.00350688871816015,0.513445824006616
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24020.Average daytime sound level of noise pollution,51175,-0.000461820728890326,0.00245098447205905,-0.00526575029412606,0.00434210883634541,0.850546859605478
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24021.Average evening sound level of noise pollution,51175,-0.000495717631735939,0.00245068339341615,-0.00529905708283159,0.00430762181935971,0.839701481213679
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24022.Average night-time sound level of noise pollution,51175,-0.000464166239256464,0.00245095234927921,-0.00526803284384371,0.00433970036533078,0.849794875336576
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51175,-0.000454997018827461,0.00245072494302802,-0.00525841790716238,0.00434842386950746,0.852714271082296
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51175,-0.000459179552914132,0.00245073535556115,-0.00526262084981398,0.00434426174398571,0.851376677428734
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48285,0.00275518371344086,0.00286826324011546,-0.00286661223718544,0.00837697966406717,0.336775341560662
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48285,-0.00295672361084306,0.00261843902521813,-0.0080888641002706,0.00217541687858448,0.258827695872563
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24502.Water percentage, buffer 1000m",48285,-0.000697375649836973,0.00256959569388288,-0.00573378320984741,0.00433903191017346,0.786089529989653
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48285,0.00341033589130969,0.00270268754151029,-0.00188693169005047,0.00870760347266986,0.207021824598682
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48285,-0.00331757543433921,0.00263760394562792,-0.00848727916776994,0.00185212829909151,0.208476804391946
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24505.Water percentage, buffer 300m",48285,0.000950693662766351,0.00258542592640113,-0.00411674115297987,0.00601812847851257,0.713090817402946
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51332,0.00273318157415514,0.00272954747262518,-0.0026167314721902,0.00808309462050049,0.316675634104041
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51332,0.0017809971016761,0.0025757353598734,-0.00326744420367578,0.00682943840702797,0.489287571552217
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X24508.Distance (Euclidean) to coast,51332,0.000604038597923775,0.00246402178638442,-0.00422544410338968,0.00543352129923723,0.806347296248528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35393,-0.00330598802603034,0.0474300882393295,-0.0962689609751162,0.0896569849230555,0.944431855078063
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2704.Years since last cervical smear test,45007,-0.0360764358399837,0.0334465044632887,-0.10163158458803,0.0294787129080621,0.2807649234995
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2714.Age when periods started (menarche),50681,0.00185184150529752,0.0290576027417903,-0.0551010598686115,0.0588047428792065,0.94918568918848
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2734.Number of live births,51502,-0.00584616769307904,0.0278160345051384,-0.0603655953231503,0.0486732599369922,0.833534564249165
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2744.Birth weight of first child,45908,0.0223630287745214,0.0306548278328105,-0.0377204337777871,0.0824464913268299,0.46569721483595
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2754.Age at first live birth,42701,0.00334802087627925,0.00308814278115232,-0.0027047389747793,0.00940078072733781,0.278311057668973
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2764.Age at last live birth,42653,0.00352746007267207,0.00298409680365273,-0.00232136966248729,0.00937628980783143,0.237186886337273
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2794.Age started oral contraceptive pill,45182,0.00278883693297661,0.00339346189117969,-0.00386234837373558,0.00944002223968881,0.411185097033513
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2804.Age when last used oral contraceptive pill,43267,0.000420748317438382,0.00296551018517737,-0.00539165164550927,0.00623314828038603,0.887175849823542
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2867.Age started smoking in former smokers,29932,0.00469158552306828,0.00549151773319051,-0.00607178923398513,0.0154549602801217,0.392957774910291
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35295,-0.0142813902209821,0.0503929946759857,-0.113051659785914,0.0844888793439498,0.776875403658569
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35289,-0.0393168495828535,0.0561913044073893,-0.149451806221337,0.0708181070556295,0.484131988905829
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35326,0.0777223229545023,0.0558515381007777,-0.031746691723022,0.187191337632027,0.164075704543114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35282,0.00561325641173965,0.057215888091618,-0.106529884247832,0.117756397071311,0.921849460391363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28739.Difficulty with standing for long periods,35339,0.0633013065617174,0.0480124482369156,-0.0308030919826371,0.157405705106072,0.187385713792555
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28740.Difficulty with taking care of household responsibilities,35367,0.0786252658132039,0.05150671890707,-0.0223279032446532,0.179578434871061,0.126913119868317
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28741.Difficulty learning a new task,35260,-0.0895863936430941,0.0640074249931055,-0.215040946629581,0.0358681593433926,0.161654345573629
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28742.Difficulty with joining in community activities,34986,0.0411404899724952,0.0614005674769081,-0.0792046222822447,0.161485602227235,0.502850577870822
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28743.Difficulty with being emotionally affected by health problems,35292,0.047996367455123,0.0512670509000509,-0.0524870523089768,0.148479787219223,0.349189534561192
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35359,0.00028560221061079,0.0776880311364639,-0.151982938816859,0.15255414323808,0.997066834451282
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29902,0.0819406219803927,0.0713378361164322,-0.0578815368078143,0.2217627807686,0.250759897230638
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2897.Age stopped smoking,29944,0.00474663937344954,0.00563061968951247,-0.00628937521799491,0.015782653964894,0.399262469737941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34244,0.00960552825541888,0.00818718764159966,-0.00644135952211645,0.0256524160329542,0.240728493867635
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34244,-0.00495308341150425,0.00872821934392348,-0.0220603933255943,0.0121542265025858,0.570401626540884
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34244,-0.00415889293031059,0.0291228516483834,-0.061239682161142,0.0529218963005209,0.886447015154697
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34244,0.0379762872083271,0.0305098893459793,-0.0218230959097923,0.0977756703264465,0.213264267242017
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34244,-0.0135340624101122,0.0324908276493924,-0.0772160846029214,0.050147959782697,0.677016534600633
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34244,-0.00868501818059245,0.0267093489806139,-0.0610353421825957,0.0436653058214108,0.745061083082639
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34244,0.00491900267098764,0.0123452449125731,-0.0192776773576556,0.0291156826996308,0.690304817201043
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34244,-0.0238567689651045,0.022063971430452,-0.0671021529687903,0.0193886150385813,0.279610537451647
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29002.Recent lack of interest or pleasure in doing things,34174,0.0399298370264986,0.0598637236165226,-0.0774030612618857,0.157262735314883,0.504780141457444
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29003.Recent feelings of depression,34161,0.058322170467888,0.0566635197839639,-0.0527383283086813,0.169382669244457,0.303377554360532
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34181,-0.0570926640795966,0.0488542276945506,-0.152846950360916,0.0386616222017226,0.242580154784137
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29005.Recent feelings of tiredness or low energy,34186,-0.0237013398569165,0.0489432779978866,-0.119630164732774,0.0722274850189413,0.628211270624084
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29006.Recent poor appetite or overeating,34193,-0.0305178610176635,0.0654143453629459,-0.158729977929037,0.0976942558937105,0.640845449448651
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29007.Recent feelings of inadequacy,34147,0.0412795626600228,0.0633007711314027,-0.0827899487575264,0.165349074077572,0.514340613796946
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29008.Recent trouble concentrating on things,34193,0.0228802287720965,0.0635899015817452,-0.101755978328124,0.147516435872317,0.71899765793392
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34180,0.136267615916672,0.099061410965991,-0.0578927495766698,0.330427981410015,0.168981128306404
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29010.Recent thoughts of suicide or self-harm,34116,0.0841668532398846,0.1189468784639,-0.14896902854936,0.317302735029129,0.479210540455247
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#0.Substances taken for depression_None of options listed,32951,0.0175439637506637,0.01552898531071,-0.0128928474583279,0.0479807749596554,0.258610952427611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32951,-0.0165104504838613,0.0311392560713451,-0.0775433923836976,0.044522491415975,0.595977840824795
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32951,-0.000699662440249242,0.0146607007731326,-0.0294346359555891,0.0280353110750906,0.961937591284411
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32951,-0.0539239692626101,0.0421943756882994,-0.136624945611677,0.0287770070864567,0.201288030029346
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32951,0.00686314403683587,0.0266976268205766,-0.0454642045314943,0.0591904926051661,0.797131389501447
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32951,0.0096047632743256,0.0281730749670648,-0.0456144636611213,0.0648239902097725,0.733172273541519
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32951,0.0305719723289296,0.0315813472876621,-0.0313274683548881,0.0924714130127473,0.333052494065486
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32951,-0.0353671265178743,0.0380615058860995,-0.109967678054629,0.0392334250188808,0.35280672883149
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32951,-0.050353898795555,0.0288696143554187,-0.106938342932176,0.00623054534106556,0.0811632860585792
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32951,-0.0239303119793021,0.0156797563088031,-0.0546626343445562,0.00680201038595205,0.126999371635955
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32951,0.029691083926753,0.0236972071534861,-0.0167554420940798,0.0761376099475857,0.210263469766982
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32951,0.0275107945520976,0.036775222876203,-0.0445686422852603,0.0995902313894555,0.45443283626102
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32951,0.010401575634208,0.0491459491931055,-0.0859244847842787,0.106727636052695,0.832387785036612
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32951,0.0742427727029872,0.0315672400603404,0.0123709821847201,0.136114563221254,0.0187008372479857
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32951,-0.0114038662231026,0.0534460163382003,-0.116158058245975,0.0933503257997701,0.83104218691992
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32951,-0.0809915032550586,0.0511343644944263,-0.181214857664134,0.0192318511540169,0.113254648226072
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32951,0.0227859482593898,0.0270603965422,-0.0302524289633221,0.0758243254821018,0.399789009722816
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32951,0.0329273518034487,0.0266545275475207,-0.0193155221896919,0.0851702257965894,0.216738868828966
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32951,0.0152603943734747,0.0364765208870405,-0.0562335865651246,0.0867543753120741,0.675692952935003
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29058.Recent feelings or nervousness or anxiety,34032,0.0441824149241219,0.0539895822017691,-0.0616371661913455,0.150001996039589,0.413177295624621
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29059.Recent inability to stop or control worrying,34045,-0.0111835210401923,0.057436189650259,-0.1237584527547,0.101391410674315,0.84562246376123
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29060.Recent worrying too much about different things,34036,0.00251097082820229,0.0532796750574594,-0.101917192284418,0.106939133940823,0.962412099235249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29061.Recent trouble relaxing,34043,-0.0106906808287739,0.0561800006605841,-0.120803482123519,0.0994221204659708,0.849083288379483
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29062.Recent restlessness,34054,-0.0420287149691469,0.0849655840323509,-0.208561259672555,0.124503829734261,0.620854459225615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29063.Recent easy annoyance or irritability,34022,-0.00589857842634112,0.0590783428487841,-0.121692130409958,0.109894973557276,0.920470800041713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29064.Recent feelings of foreboding,34007,0.0552299597328756,0.0615913900809881,-0.0654891648258611,0.175949084291612,0.369893295480043
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32951,-0.010906186840715,0.0153203177654316,-0.0409340096609608,0.0191216359795309,0.476560283437857
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32951,-0.0428432835487103,0.0267760353162739,-0.0953243127686072,0.00963774567118668,0.109622272495769
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32951,-0.0355365819460129,0.0332872075742704,-0.100779508791583,0.0297063448995571,0.28574270602189
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32951,-0.061711722611851,0.0367633973374868,-0.133767981393325,0.0103445361696231,0.0932631611439328
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#2.Symptoms of panic attack_Sweating,32951,0.0115769219252632,0.0250547684895372,-0.0375304243142298,0.0606842681647562,0.644046812699521
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32951,-0.0151600695311892,0.0250240114917286,-0.0642071320549772,0.0338869929925989,0.544649857906558
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32951,0.0173515503892358,0.025578366695536,-0.0327820483340148,0.0674851491124865,0.497556740308181
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32951,0.00335254816831591,0.0228814972255693,-0.0414951863938,0.0482002827304318,0.883516061295737
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32951,0.0219069963015868,0.0306006947189832,-0.0380703653476203,0.0818843579507938,0.47407359488548
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29076.Felt loved as a child,34012,0.0186116799170544,0.0517807552361686,-0.082878600345836,0.120101960179945,0.719279598877582
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29077.Physically abused by family as a child,34029,-0.0584703430019275,0.0768739888338394,-0.209143361116253,0.0922026751123978,0.446914850997394
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29078.Felt hated by family member as a child,34007,-0.0251069569207882,0.068727401706359,-0.159812664265252,0.109598750423675,0.714886476198956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29079.Sexually molested as a child,33897,-0.0858058691572925,0.0933354019028728,-0.268743256886923,0.0971315185723383,0.357947404798988
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29080.Someone to take to doctor when needed as a child,33979,0.0974774336081444,0.0809666777688621,-0.0612172548188254,0.256172122035114,0.228650273913645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34007,0.070690835976688,0.0856529925672563,-0.0971890294551342,0.23857070140851,0.40921248043404
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29082.Belittlement by partner or ex-partner as an adult,33928,-0.105671204120196,0.0749466089068643,-0.25256655757765,0.0412241493372579,0.158586353457351
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34009,0.0349939917692214,0.0747591546193756,-0.111533951284755,0.181521934823198,0.639731105769763
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,33967,0.0896314194466134,0.0880181492597009,-0.0828841531024003,0.262146991995627,0.308547603438391
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,33972,0.0658485433139849,0.0902101460791601,-0.110963343001169,0.242660429629139,0.465441100919758
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29086.Experienced a violent or sexual assault,34006,-0.0261235132629617,0.0919591420934748,-0.206363431766172,0.154116405240249,0.776357228823438
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29087.Experienced a life-threatening injury or illness,34011,-0.154884220815305,0.0712112001402872,-0.294458173090268,-0.0153102685403424,0.0296546962020507
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29088.Experienced a marital separation or divorce,34020,-0.00587123804515373,0.0562533461779743,-0.116127796553983,0.104385320463676,0.916876840619341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29089.Experienced the death of a spouse or partner,34030,0.0354892935126281,0.0688414424341813,-0.0994399336583672,0.170418520683623,0.606200043333682
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34014,-0.0610250517286169,0.0748881433745918,-0.207805812742817,0.0857557092855829,0.415159759354562
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29091.Frequency of drinking alcohol,34026,0.0383160040655386,0.0469180914671549,-0.0536434552100851,0.130275463341162,0.414144599115892
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32801,0.0253049033771928,0.0564649450817363,-0.0853663889830104,0.135976195737396,0.654054811256857
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32820,0.0197347318692254,0.0580458499582047,-0.0940351340488558,0.133504597787307,0.733876184339518
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29104.Ever used cannabis,34020,0.000709453288802991,0.0725901032359076,-0.141567149053576,0.142986055631182,0.992202270098492
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29108.Ever thought that life not worth living,33967,-0.0207400657786256,0.0575571260748339,-0.1335520328853,0.0920719013280488,0.718601785876077
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29109.Ever contemplated self-harm,34002,-0.109713472128016,0.0824061444795405,-0.271229515307916,0.051802571051883,0.183097467352716
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29111.Ever self-harmed,34016,0.0245161534957718,0.11621256896694,-0.203260481679431,0.252292788670974,0.832923315313564
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34010,0.00695058461137574,0.0824135319818846,-0.154579938073118,0.168481107295869,0.932789542581731
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33641,0.014561856209202,0.0331563554564098,-0.0504246004853611,0.0795483129037652,0.660536022785114
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33641,-0.0336799870429071,0.0256501986837599,-0.0839543764630765,0.0165944023772622,0.189198972134029
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33641,0.00277358754954825,0.0259090660025622,-0.0480081818154737,0.0535553569145702,0.914750975670222
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33641,-0.0164187805404286,0.0332127772709908,-0.0815158239915706,0.0486782629107134,0.621069899174151
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34006,0.0695822372095216,0.0511263939162573,-0.0306254948663428,0.169789969285386,0.173550644972652
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X29153.Pain or discomfort today,34017,-0.0370782617167887,0.0514704171449189,-0.13796027932083,0.0638037558872524,0.471308638522585
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29154.Anxiety or depression today,34017,-0.000476898142047144,0.0602708112690189,-0.118607688229324,0.11765389194523,0.99368689855976
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29166.Frequency of confiding in someone close,33772,-0.0714436764651335,0.0484531329539858,-0.166411817054946,0.0235244641246787,0.14038340787683
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,33981,-0.00564716848628531,0.00867073216223469,-0.0226418035242653,0.0113474665516947,0.514874461938969
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,33981,0.0148557326898556,0.0084934559558724,-0.00179144098365434,0.0315029063633655,0.0803094115759617
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,33981,-0.0167911611811524,0.0123438172858116,-0.0409850430613432,0.00740272069903838,0.173770606084552
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,33981,-0.00508813564164923,0.0108598518686232,-0.0263734453041508,0.0161971740208523,0.639418364399962
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,33981,-0.0108202343764022,0.016092665058295,-0.0423618578906603,0.0207213891378559,0.501364116287645
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,33981,-0.00277679736160009,0.00849868367578512,-0.0194342173661389,0.0138806226429387,0.743877286237565
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,33982,-0.00141051797057403,0.00946470846172751,-0.01996134655556,0.0171403106144119,0.88153374195268
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,33982,-0.00359182652997171,0.0132449459876775,-0.0295519206658196,0.0223682676058761,0.786254863458503
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,33982,0.0319466201369718,0.02745410003449,-0.0218634159306286,0.0857566562045722,0.244600083107166
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,33982,-0.000606447976786831,0.0183016462846443,-0.0364776746946896,0.035264778741116,0.973566627052532
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,33982,-0.00853519209859947,0.025693532522427,-0.0588945158425564,0.0418241316453575,0.739751409466615
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,33982,-0.00458854670344583,0.0134803831824272,-0.0310100977410031,0.0218330043341115,0.733572637030418
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29171.Frequency of feeling 'in tune' with people,33877,0.0436858618374247,0.063985322112067,-0.0817253695022265,0.169097093177076,0.49478276548318
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29172.Freuency of feeling that lacks companionship,33959,0.0601591434954673,0.0536385689009083,-0.044972451550313,0.165290738541248,0.262075754666327
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29173.Frequency of feeling left out,33902,4.91259348143782e-05,0.0568932232095697,-0.111461591555942,0.111559843425571,0.999311064116393
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29174.Frequency of feeling isolated from others,33932,-0.0223170272314309,0.0605838873250401,-0.141061446388509,0.0964273919256477,0.712608781109701
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29175.Tendency to bounce back quickly after hard times,34002,-0.0361906410725922,0.0482673693554016,-0.130794685009179,0.0584134028639949,0.45339654571406
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29176.Ability to make it through stressful events,34002,0.0768013371394389,0.048109292875249,-0.0174928768960491,0.171095551174927,0.110434181230363
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29177.Quick recovery from stressful events,34002,-0.00748455329788946,0.0472801253088289,-0.100153598903194,0.0851844923074153,0.87422193203396
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29178.Hard to snap back when something bad happens,34002,0.00659461664321254,0.0471267412906099,-0.0857737962863829,0.098963029572808,0.888715370546341
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29179.Comes through difficult times with little trouble,34002,0.0319001472783786,0.0470426856906117,-0.0603035166752204,0.124103811231978,0.497717958232602
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29180.Tendency to take a long time to get over setbacks,34002,0.0312043650766774,0.0468964210500761,-0.0607126201814718,0.123121350334827,0.505817760621898
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29181.General happiness,33948,0.100682734199448,0.050998016420529,0.000726622015210732,0.200638846383684,0.0483824899158005
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,X29182.Belief that own life is meaningful,33852,-0.151545223274554,0.0500192217965756,-0.249582897995842,-0.053507548553266,0.00245429949036687
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29486,-0.0352793022055969,0.0722499080187721,-0.17688912192239,0.106330517511196,0.625361843806381
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2946.Father's age,30585,0.000973865362611549,0.00746763736626439,-0.0136627038752667,0.0156104346004898,0.896245190980587
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X2966.Age high blood pressure diagnosed,30236,-0.0042739472195523,0.00617735284506209,-0.016381558795874,0.00783366435676939,0.489044495651048
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30000.White blood cell (leukocyte) count,50631,0.00416120397678976,0.00259268622763337,-0.000920461029371654,0.00924286898295117,0.108510740681071
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50631,0.00415471004373837,0.0030302438908017,-0.00178456798223296,0.0100939880697097,0.170361437613669
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30020.Haemoglobin concentration,50631,0.00212049264954624,0.00330134371561933,-0.00435014103306765,0.00859112633216013,0.52067625581006
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30030.Haematocrit percentage,50631,0.00386167752808887,0.00319949775891332,-0.00240933807938124,0.010132693135559,0.227457044542962
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30040.Mean corpuscular volume,50631,-0.000450537755730797,0.00254503222895473,-0.00543880092448207,0.00453772541302047,0.859489064834707
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50630,-0.0022745425348572,0.00255060959773176,-0.00727373734641146,0.00272465227669705,0.372527487103096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50630,-0.00425740704494848,0.0024985347537851,-0.00915453516236728,0.000639721072470316,0.0884001466065278
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50631,0.00379935855771098,0.00241369742000024,-0.00093148838548949,0.00853020550091146,0.11548049171253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30080.Platelet count,50631,0.00561353512945885,0.00255971822841496,0.000596487401765535,0.0106305828571522,0.0283140883631956
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30090.Platelet crit,50631,0.00555927445530854,0.00262508497679327,0.000414107900793735,0.0107044410098234,0.0342056213107763
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50631,-0.00197737297370295,0.00247428938105421,-0.0068269801605692,0.00287223421316329,0.424200236622377
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30110.Platelet distribution width,50631,-0.0015480144611626,0.00247085939725172,-0.00639089887977597,0.00329486995745077,0.530986913894849
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30120.Lymphocyte count,50595,-0.000761834123661906,0.00257859299822329,-0.00581587640017955,0.00429220815285573,0.767655799832209
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30130.Monocyte count,50595,0.00250886801981836,0.00261288030202826,-0.00261237737215704,0.00763011341179376,0.336967230554235
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30140.Neutrophill count,50595,0.00516848443539308,0.00257399023359773,0.000123463577541533,0.0102135052932446,0.0446571912467334
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30150.Eosinophill count,50595,-0.00410578039392669,0.00253951516613901,-0.00908323011955916,0.000871669331705781,0.105942684839241
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30160.Basophill count,50595,0.0217205126651646,0.0318914768763518,-0.0407867820124849,0.0842278073428142,0.495829570634474
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30170.Nucleated red blood cell count,50595,-0.183336749366258,0.170914267014728,-0.518328712715125,0.15165521398261,0.283423480552257
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30180.Lymphocyte percentage,50595,-0.00432690480007396,0.00254468599301662,-0.00931448934638653,0.000660679746238616,0.0890734609546287
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30190.Monocyte percentage,50595,-0.00135300719680637,0.00257759909820671,-0.00640510142929152,0.00369908703567879,0.59965030177239
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30200.Neutrophill percentage,50595,0.00502791968824127,0.00252440160550042,8.00925414604367e-05,0.0099757468350221,0.0464113682648704
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30210.Eosinophill percentage,50595,-0.00498615275666732,0.00250808292290285,-0.00990199528555691,-7.03102277777277e-05,0.046818402175793
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30220.Basophill percentage,50595,0.000584933241664072,0.00239617971369332,-0.00411157899717483,0.00528144548050298,0.807146957952905
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30230.Nucleated red blood cell percentage,50595,-0.182550245516818,0.170819760999385,-0.517356977075612,0.152256486041976,0.285227492591843
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30240.Reticulocyte percentage,50161,-0.000465155690808526,0.00263873110396753,-0.00563706865458489,0.00470675727296784,0.860075311001503
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30250.Reticulocyte count,50161,7.50422915656045e-05,0.00272681893256757,-0.00526952281626684,0.00541960739939804,0.978045133194978
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30260.Mean reticulocyte volume,50161,0.000495615181881755,0.00252517179558297,-0.00445372153746086,0.00544495190122437,0.844400481313334
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30270.Mean sphered cell volume,50161,-0.000858204438282754,0.00255317308381756,-0.00586242368256518,0.00414601480599967,0.736773698487756
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30280.Immature reticulocyte fraction,50161,0.00139552611980953,0.00266607237414957,-0.00382997573352363,0.00662102797314269,0.600673337715981
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50161,0.000379506648725541,0.00270960748315204,-0.00493132401825245,0.00569033731570353,0.888613965978771
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30300.High light scatter reticulocyte count,50161,0.00114328110495132,0.00277971349503907,-0.00430495734532526,0.0065915195552279,0.680859968984546
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30500.Microalbumin in urine,31969,-0.00452426039369429,0.00468520218539183,-0.0137072566770623,0.00465873588967369,0.33425095624713
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50683,-0.00160217293821028,0.0026194417497856,-0.00673627876779005,0.00353193289136949,0.540776825059854
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30520.Potassium in urine,50629,-0.00234540361951877,0.0024362425318855,-0.00712043898201435,0.00242963174297681,0.335700203544133
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30530.Sodium in urine,50602,0.00305634617216719,0.00255125071411262,-0.00194410522749354,0.00805679757182792,0.230935837678638
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30600.Albumin,47921,0.00455612162708245,0.00277890346347552,-0.000890529161329569,0.0100027724154945,0.101114381638003
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30610.Alkaline phosphatase,50231,-0.00128295198238271,0.00259574625687155,-0.00637061464585094,0.00380471068108553,0.621132647888098
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30620.Alanine aminotransferase,50240,-0.00551372979563431,0.00270894085901751,-0.0108232538793086,-0.000204205711959993,0.0418226416090476
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30630.Apolipoprotein A,47713,-0.00154400609350906,0.00304847148466241,-0.00751901020344739,0.00443099801642926,0.612520784299524
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30640.Apolipoprotein B,50131,0.00167231640099553,0.00258349828804253,-0.00339134024356784,0.00673597304555889,0.5174390897843
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30650.Aspartate aminotransferase,50162,-0.00548063504795759,0.00261644306765598,-0.0106088634605633,-0.00035240663535187,0.0362083913937454
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30660.Direct bilirubin,44540,-0.00522720871998678,0.00288249408293305,-0.0108768971225356,0.000422479682561998,0.0697800425643213
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30670.Urea,50227,0.000168441008516621,0.00269514139924014,-0.00511403613399406,0.0054509181510273,0.950166721078828
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30680.Calcium,47926,0.00349431961622846,0.00266099670472029,-0.00172123392502331,0.00870987315748023,0.189141219145427
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30690.Cholesterol,50239,0.00324199131721092,0.00265886596731516,-0.00196938597872679,0.00845336861314863,0.222736358131766
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30700.Creatinine,50233,-0.00117734965670441,0.0029453127818701,-0.00695016270916981,0.00459546339576099,0.689353758403253
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30710.C-reactive protein,50174,-0.000876166916878211,0.00282229535022662,-0.00640786580332238,0.00465553196956596,0.756225245257637
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30720.Cystatin C,50236,-0.00112036196750681,0.00290047913543984,-0.00680530107296888,0.00456457713795527,0.699301462889242
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30730.Gamma glutamyltransferase,50235,-0.00198497112824091,0.00265363412377541,-0.00718609401084071,0.00321615175435889,0.454454977828283
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30740.Glucose,47900,0.000773270038294567,0.00287854776382538,-0.00486868357880317,0.0064152236553923,0.788215249242509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50068,0.000854717783395347,0.00285355125031993,-0.00473824266723172,0.00644767823402242,0.764539832649504
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30760.HDL cholesterol,47913,-0.00124649000580497,0.00320825499024153,-0.00753466978667838,0.00504168977506844,0.697630451636668
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30770.IGF-1,50093,0.00353242173084164,0.00259633211411237,-0.00155638921281861,0.00862123267450188,0.173670084392319
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30780.LDL direct,50183,0.00293636210572239,0.0025925086326298,-0.00214495481423202,0.00801767902567681,0.257378751815313
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30790.Lipoprotein A,45099,0.00114092171012205,0.00282118335551114,-0.00438859766667978,0.00667044108692387,0.685913625803528
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30810.Phosphate,47880,-0.00126582635528002,0.00286464408802051,-0.00688052876780022,0.00434887605724019,0.658580772875041
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30830.SHBG,47663,0.000248850276460208,0.00303855301248438,-0.00570671362800917,0.00620441418092958,0.934728828889595
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30840.Total bilirubin,50145,-0.0026271546260594,0.00261165931276011,-0.00774600687906922,0.00249169762695042,0.314457211699509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30850.Testosterone,45834,0.00778492339569503,0.00461127701380246,-0.00125317955135779,0.0168230263427479,0.0913805373090706
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30860.Total protein,47918,-0.00187524098567741,0.00271287489701152,-0.00719247578382,0.00344199381246517,0.489423110606991
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30870.Triglycerides,50231,0.000563965483619541,0.00288215824361056,-0.00508506467385715,0.00621299564109624,0.844866321074842
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30880.Urate,50206,-0.0066610122906682,0.003163174647895,-0.0128608346005424,-0.000461189980794007,0.0352314069424743
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Blood and urine assays,X30890.Vitamin D,48747,-0.0010782649755698,0.00280083815291088,-0.00656790775527512,0.00441137780413553,0.700256052202184
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3137.Number of measurements made,49161,0.0177470945845374,0.0361787498043769,-0.0531632550320413,0.0886574442011162,0.62375676200019
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3143.Ankle spacing width,39798,-0.00375540282628124,0.00427726562606566,-0.0121388434533699,0.00462803780080745,0.379962081756379
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39797,-0.00289369512001924,0.00347935713157229,-0.00971323509790093,0.00392584485786245,0.405605230839079
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3146.Speed of sound through heel,39798,-0.00380119283946813,0.00335648483993076,-0.0103799031257324,0.00277751744679615,0.257445263668941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39798,-0.00351908858693333,0.00339934726534266,-0.0101818092270049,0.00314363205313828,0.300580252877918
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X3148.Heel bone mineral density (BMD),39796,-0.00374670024184464,0.00339123147268418,-0.0103935139283056,0.00290011344461636,0.269254930962511
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X3526.Mother's age at death,40511,-0.00192431187814625,0.00323911996703571,-0.00827298701353624,0.00442436325724374,0.552463777450231
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X3581.Age at menopause (last menstrual period),39932,0.00173339736729004,0.00324666166867333,-0.00463005950330968,0.00809685423788976,0.593417386286025
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30049,-0.00539885293178687,0.00516398538067165,-0.0155202642779033,0.00472255841432957,0.295845478974176
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4100.Ankle spacing width (left),33151,0.00697278654608047,0.00630758646945946,-0.00539008293406007,0.019335656026221,0.268990752164717
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33149,0.00143349364421824,0.00516611270401396,-0.00869208725564912,0.0115590745440856,0.781418053337389
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4103.Speed of sound through heel (left),33151,-0.00304231458229055,0.0050238697480694,-0.0128890992885066,0.00680447012392547,0.544814834197022
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33151,-0.0016221347982299,0.00506623853923245,-0.0115519623351255,0.0083076927386657,0.748835602195059
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4105.Heel bone mineral density (BMD) (left),33150,-0.0016209350347315,0.00504792274502821,-0.0115148636149868,0.0082729935455238,0.748135263478393
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33151,-0.00162557244614257,0.00506594167726059,-0.0115548181335733,0.00830367324128818,0.748307082205844
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4119.Ankle spacing width (right),33156,0.00567857736710762,0.0062559836445876,-0.00658315057628408,0.0179403053104993,0.364060098587296
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33156,-0.00336492525953934,0.0051845242199482,-0.0135265927306378,0.00679674221155914,0.516334426189574
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4122.Speed of sound through heel (right),33156,-0.0041451115304569,0.00506874629837417,-0.0140798542752703,0.00578963121435647,0.413506086175077
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33156,-0.00424864364802493,0.00510396634203608,-0.0142524176784156,0.00575513038236578,0.405194756793295
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4124.Heel bone mineral density (BMD) (right),33153,-0.00418803793751649,0.00509490409169966,-0.0141740499572478,0.00579797408221485,0.41109642998613
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33156,-0.00424831838054865,0.00510397402271273,-0.0142521074650656,0.0057554707039683,0.40523142145571
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4194.Pulse rate,33413,0.00344538024315729,0.00490729265734618,-0.00617291336524122,0.0130636738515558,0.482638841098238
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4195.Pulse wave reflection index,33413,-0.00334325833669299,0.00491283807278984,-0.0129724209593611,0.00628590428597509,0.496196223635509
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4196.Pulse wave peak to peak time,33410,-0.00653360588436488,0.00449126518221112,-0.0153364856414987,0.00226927387276892,0.145777354395443
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4198.Position of the pulse wave peak,33413,0.00341037747539323,0.00433691065614502,-0.00508996741065102,0.0119107223614375,0.431676808610875
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4199.Position of pulse wave notch,33413,0.00133450635824551,0.0048301754499826,-0.00813263752372038,0.0108016502402114,0.782335335428553
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4200.Position of the shoulder on the pulse waveform,33413,0.00725139977604616,0.00433300433724168,-0.00124128872494752,0.0157440882770399,0.0942584968849027
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4269.Number of triplets attempted (left),33319,-0.0221201118575685,0.141788231286586,-0.300025045179276,0.255784821464139,0.876030197500668
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4270.Volume level set by participant (left),33232,-0.0216853890654545,0.0466463361671439,-0.113112207953057,0.0697414298221475,0.642022166149936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4276.Number of triplets attempted (right),33321,-0.053853512675901,0.130200338975515,-0.30904617706791,0.201339151716108,0.679162166646903
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X4277.Volume level set by participant (right),33214,-0.0209770594004954,0.0455078265728414,-0.110172399483265,0.0682182806822737,0.644842348156498
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4288.Time to answer,33490,-0.000931383295587794,0.00545536045404565,-0.0116238897855173,0.00976112319434168,0.864441392552829
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Cognitive function,X4290.Duration screen displayed,33490,0.00738573929038564,0.00486776521706111,-0.00215508053505414,0.0169265591158254,0.12923219974177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X46.Hand grip strength (left),51420,0.00652797616966896,0.00371540157956305,-0.000754210926274619,0.0138101632656125,0.0789284404649667
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X47.Hand grip strength (right),51425,0.00432298672801968,0.00370681145393414,-0.00294236372169124,0.0115883371777306,0.243532649382143
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X48.Waist circumference,51509,0.00204470818246937,0.00496360517112058,-0.00768395795292696,0.0117733743178657,0.680386566016008
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X4803.Tinnitus,33330,0.0393731687610104,0.0537750558287613,-0.0660259406633617,0.144772278185382,0.464076360180939
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4825.Noisy workplace,33461,0.0624071029955409,0.0696507008993397,-0.0741082707671649,0.198922476758247,0.370276133461913
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Working and living environment,X4836.Loud music exposure frequency,33408,0.0383912609004639,0.0832621675683912,-0.124802587533583,0.201585109334511,0.644746027506255
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X49.Hip circumference,51506,-0.00191144204272702,0.00421170332590524,-0.0101663805615013,0.00634349647604725,0.649947186441502
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X50.Standing height,51505,0.00596351484848112,0.00344545622410884,-0.000789579350772209,0.0127166090477344,0.0834926710506408
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X5057.Number of older siblings,32402,-0.00824297917546718,0.0484539091301463,-0.103212641070554,0.0867266827196195,0.864920091888419
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,X51.Seated height,51379,0.00338329780956231,0.0034587139614571,-0.0033957815548936,0.0101623771740182,0.327986518875957
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5181.Ever had eye surgery,30542,0.0400056303724734,0.104713670005971,-0.16523316283923,0.245244423584177,0.702439222438761
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5186.Duration visual-acuity screen displayed (right),30524,-0.0042900968442248,0.00562775875025039,-0.0153205039947156,0.00674031030626596,0.445904609583488
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5188.Duration visual-acuity screen displayed (left),30526,-0.00079234431924572,0.00557645809601264,-0.0117222021874305,0.0101375135489391,0.887015698989602
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5190.Duration at which refractometer first shown (right),30450,0.00127431761223445,0.00565030889041312,-0.00980028781297526,0.0123489230374442,0.821574198851666
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5193.Duration at which refractometer first shown (left),30451,0.000822865301186472,0.00568458136453387,-0.0103189141732999,0.0119646447756729,0.884910046882941
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5199.logMAR, initial (right)",30505,-0.102308386771599,0.0571101827003856,-0.214244344864355,0.00962757132115659,0.0732756919659768
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5200.Final number of letters displayed (right),30505,-0.256067193596027,0.259330439792918,-0.764354855590146,0.252220468398092,0.323477906885232
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5201.logMAR, final (right)",30456,-0.00270210417441792,0.00587768556819979,-0.0142223678880895,0.00881815953925367,0.64573207869264
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5202.Number of rounds to result (right),30505,-0.0939157415546118,0.0533891180357761,-0.198558412904733,0.0107269297955093,0.0786144944679703
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5206.logMAR, initial (left)",30503,-0.045791086182957,0.0573944581633553,-0.158284224183133,0.0667020518172194,0.424999798775649
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5207.Final number of letters displayed (left),30503,0.141086155663282,0.432840528426652,-0.707281280052955,0.98945359137952,0.744470339377491
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5208.logMAR, final (left)",30440,0.00246202626601741,0.00584390685125885,-0.00899203116244994,0.0139160836944848,0.673552612252424
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5209.Number of rounds to result (left),30501,-0.107582545625835,0.0537019818405353,-0.212838430033284,-0.00232666121838612,0.0451869787000212
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30212,0.00680627264021334,0.0058885901949689,-0.0047353641419257,0.0183479094223524,0.247794232541195
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30212,0.00558322385156389,0.00593856503230808,-0.00605636361175996,0.0172228113148877,0.347172972863774
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5256.Corneal hysteresis (right),30212,-0.00761358443789434,0.00588159128334198,-0.0191415033532446,0.00391433447745594,0.195552612296959
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5257.Corneal resistance factor (right),30212,-0.00196750639309586,0.00589030298659212,-0.0135125002468164,0.00957748746062469,0.738373118006679
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30213,0.00160097718165545,0.00586259977768706,-0.00988971838261119,0.0130916727459221,0.784799091645718
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30213,-0.000254064021615435,0.00583571777346676,-0.0116920708576103,0.0111839428143794,0.965275747627896
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5264.Corneal hysteresis (left),30213,0.000356836621998784,0.00596357180031252,-0.0113317641066137,0.0120454373506113,0.952288283143591
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X5265.Corneal resistance factor (left),30213,0.000330222950283306,0.0058956585065042,-0.0112252677224649,0.0118857136230315,0.955334821457959
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29811,0.099249127776478,0.210198110030103,-0.312739167882524,0.51123742343548,0.63682506678741
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51415,-0.00869159332908012,0.014448218855488,-0.0370101022858367,0.0196269156276764,0.547466460477278
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51415,-0.0146188668775323,0.0149752831501479,-0.0439704218518221,0.0147326880967575,0.328974271290115
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51415,0.00131630445720844,0.038221458833279,-0.0735977548560184,0.0762303637704353,0.972527430365893
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51415,-0.00435800370574318,0.00631875125275243,-0.016742756161138,0.00802674874965159,0.490392687002177
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51415,0.00650631205152446,0.00577539463276373,-0.00481346142869245,0.0178260855317414,0.259939795664334
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36924,7.87303950601966e-05,0.00704805003128491,-0.0137354476662582,0.0138929084563786,0.991087577304033
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36924,0.0124972529043185,0.0176181471317306,-0.0220343154738735,0.0470288212825105,0.478126897585023
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36924,0.0123373182677119,0.0137723410326061,-0.0146564701561961,0.0393311066916199,0.370374738739249
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36924,-0.0111037591907999,0.00846524731034046,-0.0276956439190672,0.00548812553746745,0.189649735791737
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51498,0.00159141503595764,0.011931880881228,-0.0217950714912491,0.0249779015631644,0.893897780097267
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51498,0.00159141503595764,0.011931880881228,-0.0217950714912491,0.0249779015631644,0.893897780097267
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51498,0.0166011953126887,0.00952033160904653,-0.00205865464104253,0.0352610452664199,0.0812119090558495
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51498,-0.0191352344095469,0.0148350326984508,-0.0482118984985105,0.00994142967941668,0.197107511296425
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51498,0.049852119121643,0.0369639675762267,-0.0225972573277614,0.122301495571047,0.177454930339402
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51498,-0.0170267187312978,0.02521594484832,-0.066449970634005,0.0323965331714094,0.499531484672309
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51498,0.0380364326939701,0.0412146765648973,-0.0427443333732285,0.118817198761169,0.356075043479439
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51415,0.00837062502845443,0.00766487329668375,-0.00665252663304573,0.0233937766899546,0.274809405962282
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51415,0.0327124871032968,0.0127801795580471,0.00766333516952437,0.0577616390370692,0.0104838730448715
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51415,0.017659136851863,0.00677025836595572,0.00438943045458982,0.0309288432491362,0.00910326618826818
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51415,-0.00410916887448283,0.0125385087492971,-0.0286846460231051,0.0204663082741394,0.743122982234132
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51415,-0.00945432947179862,0.0122748522827576,-0.0335130399460034,0.0146043810024062,0.441176500647712
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51415,0.00866475908232046,0.00687020100783584,-0.0048008348930378,0.0221303530576787,0.207244482406598
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31702,0.00461192829342364,0.0260110835554412,-0.0463697954752411,0.0555936520620883,0.859272776447453
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31702,-0.0126464102478883,0.0170339411397237,-0.0460329348817468,0.0207401143859702,0.457854409715822
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31702,-0.0352795945840996,0.0218777740494101,-0.0781600317209434,0.00760084255274429,0.106879969965443
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31702,0.035421427379458,0.0194008263100758,-0.00260419218829046,0.0734470469472066,0.0679261769765722
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51409,-0.0158516713898441,0.0186031654011933,-0.052313875576183,0.0206105327964948,0.394168722910497
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51409,-0.0540510980135507,0.0321182614139634,-0.117002890384919,0.00890069435781757,0.0924103971081802
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51409,0.0226550800366754,0.0513590256717565,-0.0780086102799673,0.123318770353318,0.659135489353144
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51409,0.0140370124760115,0.0493294179609408,-0.0826486467274325,0.110722671679455,0.775986035192024
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51409,-0.000820545745584653,0.0155691118309915,-0.0313360049343281,0.0296949134431588,0.957968588926107
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51409,-0.00566452818104446,0.0221281014748397,-0.0490356070717303,0.0377065507096414,0.797962065604369
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51409,-0.00717800489978494,0.011038588735563,-0.0288136388214884,0.0144576290219185,0.515526778360992
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33723,0.0143192451192235,0.0162741870560234,-0.0175781615105823,0.0462166517490293,0.378950009001716
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33723,0.0132304522942136,0.0188914595855708,-0.0237968084935051,0.0502577130819323,0.483732323671164
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33723,0.00494979693696235,0.0246774594021612,-0.0434180234912735,0.0533176173651982,0.841031647071388
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33723,-0.0107358037927006,0.00850079561750378,-0.027397363203008,0.00592575561760679,0.206650581617447
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37223,-0.00338246180465972,0.00870228350032644,-0.0204389374652995,0.0136740138559801,0.697514406112525
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37223,0.0105968919353602,0.00760388776488432,-0.00430672808381303,0.0255005119545335,0.163458151395962
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37223,0.00213308192353451,0.00712936048675565,-0.0118404646305066,0.0161066284775756,0.764794750810626
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37223,-0.00680361203612316,0.0171124414263901,-0.0403439972318477,0.0267367731596013,0.690944400781583
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37223,-0.00699929039864791,0.0102782496539998,-0.0271446597204876,0.0131460789231918,0.495896002835448
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37223,-0.010194707000156,0.0118836860573688,-0.0334867316725989,0.0130973176722868,0.39097806206705
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51415,-0.0186890779728367,0.0166483241566302,-0.0513197933198319,0.0139416373741586,0.261625852174096
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51415,0.00117203985330394,0.0107009053901959,-0.01980173471148,0.0221458144180878,0.912785190207314
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51415,0.024718204505356,0.0416069916606091,-0.0568314991494379,0.10626790816015,0.552458400804935
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51415,-0.00886766304204404,0.0105391603036217,-0.0295244172371426,0.0117890911530545,0.400130626837028
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51415,-0.0194895311195842,0.0126922537026978,-0.0443663483768719,0.00538728613770354,0.124661660596355
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51415,0.00461493334969104,0.0142524814559522,-0.0233199303039753,0.0325497970033574,0.746093037817471
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51415,0.00440529254090166,0.00504966617398732,-0.00549205316011349,0.0143026382419168,0.383001881601936
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28696,-0.0199168387006903,0.0168836453886614,-0.0530087836624667,0.0131751062610861,0.238204459214427
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28696,0.0053841692986478,0.0221558210305875,-0.0380412399213038,0.0488095785185994,0.80800648190361
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28696,0.0108202871667643,0.0148415635979636,-0.0182691774852443,0.0399097518187729,0.466009434432379
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28696,-0.00356144041630065,0.0133818112864169,-0.0297897905376777,0.0226669097050764,0.790144018249946
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51540,0.00103811097937267,0.00574696549569705,-0.0102259413921935,0.0123021633509389,0.856654358525068
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51540,0.00206003760653359,0.0154459001055032,-0.0282139266002527,0.0323340018133198,0.893900843738287
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51540,0.00630415072908237,0.00561483440926594,-0.00470092471307887,0.0173092261712436,0.261546419583353
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51540,0.00436362138248141,0.00559459626530674,-0.00660178729751979,0.0153290300624826,0.435414913657018
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51540,0.0133870364875397,0.00806387842338227,-0.00241816522228959,0.0291922381973689,0.0969011246732282
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51540,0.000603036344624327,0.00714692501519224,-0.0134049366851525,0.0146110093744011,0.932757288837231
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51540,0.000623589362753864,0.00599918753507961,-0.0111348182060022,0.0123819969315099,0.91721326061989
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51540,-0.00223890099436216,0.0164454816338487,-0.0344720449967057,0.0299942430079814,0.891710987230641
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43085,-0.00137475139579743,0.00609482387693799,-0.0133206061945959,0.010571103403001,0.821545755298653
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43085,-0.00269977972944182,0.00675146276065633,-0.0159326467403282,0.0105330872814446,0.689248963763858
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43085,0.000781631533338723,0.00677420576336802,-0.0124958117628626,0.01405907482954,0.908142404414829
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43085,-0.00548533717054475,0.0086622602274172,-0.0224633672162825,0.011492692875193,0.526581119489024
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43085,0.00142041947086007,0.00613830441900105,-0.010610657190382,0.0134514961321021,0.817004602988517
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51297,0.00559844027642167,0.00608664014591969,-0.00633137440958093,0.0175282549624243,0.357689955858401
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51297,0.0025848062845856,0.00489843649990397,-0.00701612925522617,0.0121857418243974,0.597725915535066
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51297,-0.000779083478694653,0.00535749383063952,-0.0112797713867481,0.00972160442935881,0.884380849051365
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51297,0.00835665467356561,0.0117233240373527,-0.0146210604396456,0.0313343697867768,0.475961504879703
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51309,-0.00400237734220385,0.0055347730661308,-0.0148505325518202,0.00684577786741251,0.46960444194288
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51309,0.00543257664627896,0.00993130140755795,-0.0140327741125346,0.0248979274050925,0.584372570151984
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51415,-0.00997684815834773,0.00527586084432731,-0.0203175354132293,0.000363839096533808,0.0586301126710711
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51415,-0.0148627574743018,0.00599321445888281,-0.0266094578137121,-0.00311605713489145,0.0131468455562761
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51415,-0.00536967369133451,0.00782431431749038,-0.0207053297536157,0.00996598237094662,0.492542196847611
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51415,-0.0163471319603893,0.0112817168542121,-0.0384592969946451,0.00576503307386646,0.147351087425446
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51415,0.00173288674317426,0.0116470753630311,-0.0210953809683668,0.0245611544547153,0.881725982805565
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51415,-0.0222817797083147,0.0149879091838458,-0.0516580817086525,0.00709452229202316,0.13711888782387
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39798,-0.00351850277384899,0.00339934535994929,-0.0101812196793496,0.00314421413165161,0.300660448180214
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X864.Number of days or week walked 10+ minutes,50914,-0.0293604311198602,0.0285315655075916,-0.0852822995147398,0.0265614372750195,0.303465198444429
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X874.Duration of walks,46926,0.00175213127395561,0.00272760457413838,-0.00359397369135562,0.00709823623926684,0.520639544343447
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49862,-0.00227263075832336,0.0278129879001263,-0.0567860870425708,0.0522408255259241,0.934877068693466
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X894.Duration of moderate activity,43813,0.0520267950332641,0.0347045758060903,-0.0159941735466728,0.120047763613201,0.133855286542417
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X90087.No-wear time bias adjusted average acceleration,30297,-0.00201381383599435,0.00556371460722109,-0.0129186944661477,0.00889106679415897,0.717398808003192
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49859,-0.0144644848428495,0.0289272019133695,-0.0711618005930538,0.0422328309073548,0.617057894146546
ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,Physical activities,X914.Duration of vigorous activity,37834,-0.00179697499067103,0.00352346447676524,-0.0087029653651309,0.00510901538378884,0.610058260820468
